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ABSTRACT  
   
This dissertation was guided by the Ecological Model of Physical Activity and 
Ecological Model of Obesity and sought to determine the relationship between active 
transportation (AT), physical activity, and cardiometabolic health among adults and 
ethnic minority women.  Chapter 2 presents an investigation into the relationship between 
walking for AT and cardiometabolic health among adults through systematic review.  
Chapter 3 presents an exploration of the cross-sectional relationships of AT and 
moderate-to-vigorous physical activity (MVPA) with cardiometabolic health among 
African American (AA) and Hispanic/Latina (HL) women from Texas.  Chapter 4 
presents an investigation into the cross-sectional relationship of AT on cardiometabolic 
health and physical activity among primarily HL women. 
In Chapter 2, walking for AT was found to be related to smaller waist 
circumference, lower blood pressure, and lower prevalence of abdominal obesity and 
hypertension, and that differences may exist based on sex.  Walking for AT was not 
clearly defined, and criteria used to determine the presence of cardiometabolic outcomes 
were inconsistent.  No significant relationships between AT and cardiometabolic health 
were found in Chapter 3 or 4; however, AT users had slightly better cardiometabolic 
health.  AT users had significantly higher levels of self-reported total physical activity 
compared to those who did not use AT in Chapter 3.  Furthermore, a significant 
relationship was found between MVPA and diastolic blood pressure. Associations 
differed by ethnicity, with MVPA being inversely related to body fat in both AA and HL 
women, but to body mass index only in AA women.  AT users were found to be seven 
times more likely to meet 2018 national MVPA recommendations than non-AT users in 
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Chapter 4.  Across all studies, measures of AT were subjective and of low quality, 
potentially limiting the ability to detect significant findings.   
High quality randomized controlled studies should be conducted using clearly 
defined, objective measures of AT, and analyzed based on sex and race/ethnicity.  
Clinicians should recommend AT use to promote meeting MVPA recommendations 
where appropriate, potentially resulting in improved cardiometabolic health.  
Policymakers should advocate for changes to the built environment to encourage AT use 
and MVPA to improve public health. 
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CHAPTER 1 
INTRODUCTION 
It is estimated that approximately 25% of the world population has 
cardiometabolic syndrome with a global economic burden into the trillions of dollars 
(Saklayen, 2018).  Cardiometabolic syndrome is a preventable medical condition 
indicated by a combination of three or more of five recognized risk factors that, together, 
increases risks for coronary artery disease, stroke, type 2 diabetes mellitus, and 
cardiovascular disease, and resulting in significantly increased morbidity and mortality 
(Alberti et al., 2009; National Heart Lung and Blood Institute, n.d.).  Cardiometabolic 
syndrome risk factors include:  a) abdominal obesity (≥88 cm for women), b) low high-
density lipoproteins (<50 mg/dL for women) or taking medication for low high density 
lipoproteins, c) high triglycerides (≥150 mg/dL) or taking medication to lower 
triglycerides, d) elevated fasting blood glucose (≥100 mg/dL) or taking medication to 
lower blood sugar, and e) hypertension (≥130 mmHg systolic and/or ≥85 mmHg 
diastolic) or taking medication to treat high blood pressure (Alberti et al., 2009; National 
Heart Lung and Blood Institute, n.d.).  These risk factors are the same as some 
cardiovascular disease risk factors, which contribute to numerous cardiovascular diseases 
(Saklayen, 2018) and are responsible for the largest cause of death across the globe 
(World Health Organization, 2017).   
 The prevalence of cardiometabolic syndrome for adults in the United States is 
approximately 33% overall, with women having a higher rate (36%) than men (30%) 
(Aguilar, Bhuket, Torres, Liu, & Wong, 2015).  Further disaggregation the rates for 
women by ethnicity and age group shows that Hispanic (10.9%, age 18-29; 24.5%, age 
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30-49; 56.9%, age 50-69, and 69% ≥ 70) and non-Hispanic black (9.1%, 27%, 52.7%, 
and 63.7%) women are disproportionally affected by cardiometabolic syndrome, 
compared to non-Hispanic white women (7.8%, 21.9%, 42.5%, and 62.1%) across the 
life span (Moore, Chaudhary, & Akinyemiju, 2017).  The upward trend in the incidence 
of cardiometabolic syndrome as women age demonstrates the need to intervene in early 
adulthood to prevent, delay, and/or treat cardiometabolic syndrome.  According to these 
projections, women with cardiometabolic syndrome could drive significantly higher 
health care costs in an already overstressed U.S. health care system, demonstrating the 
need for innovative and sustainable solutions to prevent and reduce this health disparity.  
Physical activity participation is an effective method to prevent, treat, or delay 
cardiometabolic syndrome, type 2 diabetes mellitus, obesity, hypertension, and 
cardiovascular diseases in adults (Physical Activity Guidelines Advisory Committee, 
2018).  The evidence for improving cardiometabolic syndrome with physical activity has 
been conducted primarily investigating leisure-time physical activity and includes 
epidemiological studies, randomized controlled trials, systematic reviews, meta-analyses, 
and cross-sectional studies (Pedersen & Saltin, 2015; Physical Activity Guidelines 
Advisory Committee, 2018).  The impact of physical activity on each of the 
cardiometabolic syndrome risk factors can vary depending on the “dose” or frequency, 
duration, intensity, and type of physical activity; however, benefits can be found for 
participation at frequencies ranging from one to five days per week (Physical Activity 
Guidelines Advisory Committee, 2018).   
The literature investigating abdominal obesity found that it can take at least three 
months of regular moderate physical activity to demonstrate any improvements, without 
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reference to duration (Pedersen & Saltin, 2015).  High-density lipoproteins appear to be 
the cardiometabolic syndrome risk factor that takes longer bouts of physical activity to 
change.  In a meta-analysis, the duration of exercise needed to increase high-density 
lipoproteins was greater than 120 minutes per week, with larger improvements seen with 
longer bouts regardless of intensity; however, these effects were very modest (Kodama et 
al., 2007).  According to Pedersen & Saltin (2015), lengthy bout durations of at least 60 
minutes were needed to impact high-density lipoproteins.  Similarly, triglycerides were 
also found to be more influenced by the duration of physical activity, independent of 
intensity.  
Low intensity and moderate intensity breaks in sedentary behavior have shown to 
improve glucose responses, with multiple moderate intensity breaks more effective than 
one long bout (Chastin, Egerton, Leask, & Stamatakis, 2015).  Furthermore, taking 2-
minute breaks of light intensity physical activity during sedentary behavior every 20 
minutes (totaling 28 minutes for the day) reduced blood glucose (Dunstan et al., 2012).  
According to Kraus & Slentz (2009), with stronger improvements in insulin sensitivity 
for moderate intensity physical activity than vigorous.  There is a strong body of evidence 
indicating that replacing sedentary time with light physical activity can prevent type 2 
diabetes mellitus (Physical Activity Guidelines Advisory Committee, 2018).   
Moderate intensity physical activity in accumulated amounts totaling at least 30 
minutes per day with the goal of 150 minutes per week can decrease blood pressure 
chronically, after approximately 3 months of regular participation (Brook et al., 2013).  
Physical activity improves blood pressure, but effects are even more significant at higher 
intensities (Cornelissen & Smart, 2013). Three ten-minute bouts of vigorous physical 
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activity throughout the day can be more effective at lowering blood pressure than one 30-
minute bout (Angadi et al., 2010; Bhammar, Angadi, & Gaesser, 2011).   
Even though the duration, frequency, and intensity required to improve 
cardiometabolic health outcomes differ depending on which outcome, the Physical 
Activity Advisory Committee (2018) determined that participating in at least 150 minutes 
of moderate intensity aerobic physical activity per week can improve cardiometabolic 
health risk factors.  However, they also found that replacing sedentary behavior with any 
amount or intensity of physical activity has health promoting effects.  The vast majority 
of the research from which these recommendations were drawn were based on aerobic 
physical activity and did not provide evidence based on sex.  Some of the research gaps 
identified in the report included the inability to provide specific physical activity 
recommendations based on sex or race/ethnicity and recommendations for transportation 
related physical activity participation to improve health.  Recommendations for future 
research include investigating these variables. 
The 2018 national physical activity recommendations include at least 150 minutes 
of moderate intensity aerobic physical activity per week combined with two days of 
weight training of all major muscle groups to provide the best opportunity to improve 
cardiometabolic health (Physical Activity Guidelines Advisory Committee, 2018).  
Unfortunately, even with the multiple health benefits, only 21% of Americans met these 
recommendations in 2014, with substantial differences by gender and race. About one 
fourth (25.4%) of men met recommendations compared to 17.6% of women.  Men of all 
races/ethnicities met recommendations at higher levels than the corresponding women, 
including Hispanics (19.1% vs. 11.5%), non-Hispanic black (27.8% vs. 13.4%), and non-
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Hispanic whites (26.8% vs. 20.6%), respectively.  When looking at percentages of those 
who met only the aerobic recommendations, men for each race/ethnicity also met aerobic 
recommendations at higher levels among Hispanic (47.0% vs. 38.2%), non-Hispanic 
black (47.5% vs. 35.5%), and non-Hispanic white (56.4% vs. 50.9%) women, 
respectively (Blackwell, Lucas, & Clarke, 2014).  This demonstrates a significant 
disparity among women for meeting either minimum physical activity recommendations; 
however, this was highest in Hispanic and non-Hispanic black women. 
There are a number of barriers experienced by minority women that inhibit 
participation in physical activity.  One of the most common barriers cited by both 
Hispanic and non-Hispanic black women was lack of time (Bautista, Reininger, Gay, 
Barroso, & McCormick, 2011; Im et al., 2010; Joseph, Ainsworth, Keller, & Dodgson, 
2015; Mama et al., 2015), with Hispanic women viewing physical activity as a “waste of 
time,” because it takes away family time (Im et al., 2010).  Family obligations, 
motivation, social support, and neighborhood safety all influence participation in physical 
activity by Hispanic and non-Hispanic black women (Joseph et al., 2015; Mama et al., 
2015).  
A potential physical activity intervention that could provide a sustainable and 
contextually appropriate physical activity strategy for Hispanic and non-Hispanic black 
women is active transportation.  Active transportation is defined as walking or bicycling 
for part or all of a commute to school, work, public transit stops, or any other destination. 
Active transportation use is related to improved cardiovascular outcomes (Hamer & 
Chida, 2008), increase levels of physical activity, and decrease body weight in U.S. 
adults (Wanner, Götschi, Martin-Diener, Kahlmeier, & Martin, 2012; Xu, Wen, & Rissel, 
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2013); however, the evidence investigating health benefits of active transportation among 
Hispanic or non-Hispanic black women is absent from the literature.   
Walking is the most common method of active transportation (Reynolds, 
McKenzie, Allender, Brown, & Foulkes, 2014), the preferred form of physical activity in 
all adults (Centers for Disease Control and Prevention [CDC], 2013), and has been the 
main component of successful interventions to increase physical activity participation 
among Hispanic and non-Hispanic black women (Bland & Sharma, 2017; Ickes & 
Sharma, 2012).  Furthermore, walking provides an opportunity to be physically active 
while overcoming barriers to physical activity because it has no cost and can be a social 
endeavor (Bland & Sharma, 2017; Ickes & Sharma, 2012).  Walking for active 
transportation could provide an opportunity to provide a culturally relevant physical 
activity intervention, while including friends and/or family members.   
Unfortunately, physical activity interventions have not demonstrated 
sustainability over time among Hispanic or non-Hispanic black women, possibly due to 
the multiple roles and cultural expectations they experience, which limits their ability to 
set aside time for physical activity.  Interventions should include the family, be pragmatic 
to promote adaptation, and provide the opportunity for mothers to model the behavior to 
their children to develop healthy lifestyle habits and promote use across the lifespan.  
Incorporating active transportation into a daily routine is an innovative, culturally 
appropriate way to increase physical activity levels of an entire family, (e.g., commute to 
work, take children to school, run errands), can maximize time spent with family, and 
decrease the need for additional time to be set aside for physical activity.   
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Importance of the Problem 
Cardiometabolic syndrome disproportionately affects Hispanic and non-Hispanic 
black women, and regular participation in physical activity can improve many aspects of 
health, including preventing, delaying, and treating cardiometabolic syndrome and risk 
factors (Physical Activity Guidelines Advisory Committee, 2018).  Physical inactivity is 
a modifiable risk factor for cardiometabolic syndrome, which provides an opportunity for 
active transportation interventions to be developed and evaluated to increase physical 
activity.  The discipline of nursing is concerned with maximizing health and advocating 
for health equity, and nurses are provided a unique platform to promote and educate 
patients and the public on a variety of health topics.  They interact with patients of all 
ages, across the continuum of health and disease, providing multiple opportunities to 
advocate for increased physical activity participation through active transportation use to 
improve individual and/or family health, and mortality.  The expansive reach of nursing 
demonstrates the significance for nursing scholarship to advance the science of public 
health nursing in the area of active transportation use among adults, and Hispanic and 
non-Hispanic black women.   
There have been multiple studies, mostly observational, that have assessed the 
health benefits of active transportation among primarily white adults (Hamer & Chida, 
2008; Wanner et al., 2012; Xu et al., 2013). The association between active transportation 
use and cardiometabolic risk factors has not been investigated among Hispanic or non-
Hispanic black women. Further, most active transportation research combines walking 
and cycling, preventing specific benefits to be attributed to either method of active 
transportation.  This limits the ability for healthcare providers to recommend walking for 
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active transportation as an effective intervention to prevent, delay, or treat decrease 
cardiometabolic syndrome in these women and their families.  Furthermore, research has 
not demonstrated adequate evidence to provide recommendations for the method, dose, 
or intensity of physical activity or active transportation needed to maintain or improve 
health outcomes for Hispanic and non-Hispanic black women. This indicates there is a 
gap in the scientific literature regarding the use of active transportation among Hispanic 
and non-Hispanic black women and cardiometabolic outcomes, and the need for 
exploration, which aligns with the National Institute of Nursing Research’s mission to 
promote wellness and improve the health of families of diverse populations (National 
Institute of Nursing Research, 2016).  
Theoretical Foundation 
This study is guided by the Ecological Model of Physical Activity (EMPA) (Lee 
& Cubbin, 2009; Spence & Lee, 2003) and the Ecological Model of Obesity (EMO) (Lee 
et al., 2015). These models posits how variables at environmental levels in which an 
individual is situated can directly and indirectly impact physical activity behavior (Lee & 
Cubbin, 2009; Spence & Lee, 2003) and obesity (Lee et al., 2015) through dynamic 
linkages, while also accounting for intra-individual factors and influences.  The EMPA 
and EMO can be used to guide investigation into correlates of physical activity and/or 
obesity, and in descriptive research to determine and describe the relationships between 
variables at multiple levels of the models and how they interact to influence physical 
activity levels or obesity (Lee et al., 2015; Lee & Cubbin, 2009; Spence & Lee, 2003).   
The micro-level environment is the most proximal level of the EMPA/EMO and 
is defined as the social and physical space where an individual exists.  The meso-level 
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environment describes the interaction between people in two or more micro-level 
environments and how they influence physical activity or obesity.  The exo-level 
environment is the third distal level, and similar to the meso-level in that this level also 
includes two or more micro-level environments.  However, one of the levels is external to 
the person whose behavior/outcome is being investigated.  The most distal level to the 
individual is the macro-level environment, which encompasses the micro-, meso-, and 
exo-level environments, and is the sociocultural context of an individual.  This level 
includes many broad level influences that can affect multiple individuals.  Local policies, 
cultural background and/or socioeconomic status are examples of the macro-level 
environment (Lee et al., 2015; Lee & Cubbin, 2009; Spence & Lee, 2003). 
The intra-personal factors encompassed in the EMPA/EMO include biological 
and genetic factors, behaviors, and psychological factors.  Biological and genetic factors 
are more limiting because they are not typically amenable to change by choice and 
typically moderate effects between extra-individual factors and outcomes; however, must 
be accounted for when investigating these outcomes (Lee et al., 2015; Lee & Cubbin, 
2009; Spence & Lee, 2003).  Behaviors can include sedentary behavior, physical activity, 
and active transportation.  The psychological factors are the personal traits and cognitive 
processes that impact physical activity participation, such as self-efficacy, attitudes, and 
perceptions (e.g., environment, available time, level of difficulty) that mediate the 
relationship between extra-individual factors and an individual’s physical activity level or 
obesity.  These are the higher-level mediators that can have a direct, causal effect on 
physical activity behavior (Lee et al., 2015; Lee & Cubbin, 2009; Spence & Lee, 2003).  
When designing interventions to positively change human behavior, these intrapersonal 
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factors, such as psychological factors, are the mediators that are the underlying process 
that must be targeted for a change in outcomes (Sidani, 2014).  The concept of pressure 
for macrosystem change include globalization, modernization, and urbanization.  These 
pressures have been found to both positively and negatively impact physical activity 
levels and obesity (Lee et al., 2015; Lee & Cubbin, 2009; Spence & Lee, 2003).   
The EMPA and EMO were extended in this investigation to test relationships 
among AT use (physical activity), total physical activity, and the presence or absence of 
CMS risk factors (health outcome) among adults.  The EMPA/EMO provided the 
framework to guide the selection of intra-individual variables and at multiple 
environmental levels and are found in Figure 1.1.  The micro-level environmental 
variables included in this collective body of research include research site and early care 
and education center.  Macro-level environmental variables included race/ethnicity and 
socioeconomic status.  The intra-individual factors include biological variables (age, sex, 
body mass index), educational level, and behavioral factors of the participants, which 
include physical activity, active transportation, and walking for active transportation.   
The outcome variables of interest include CMS risk factors, CMS, and total physical 
activity. 
Specific Aims and Research Hypotheses 
Specific Aim 1:  Determine the extent to which walking as a method of AT is related to 
improved CMS risk factors and/or CMS among adults. 
 Hypothesis 1a:  Adults who walk for AT have better cardiometabolic 
health than those who use passive modes of transportation. 
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 Hypothesis 1b:  It is expected that those engaging in more minutes of 
walking for AT increase will have fewer CMS risk factors; be less likely 
to have CMS; have lower waist circumference, triglycerides, fasting blood 
sugar, and blood pressure; and higher high-density lipoproteins.   
Specific Aim 2:  Examine associations among active transportation, physical activity, and 
CMS risk factors in a sample of African American and Hispanic/Latina women from two 
metropolitan cities in Texas, and examine these associations separately by ethnicity.    
 Hypothesis 2a:  Women who use active transportation will have lower 
body mass index, systolic and diastolic blood pressure, resting heart rate, 
and body fat percentage than women who do not use active transportation. 
 Hypothesis 2b:  Individuals who spend more time in active transportation 
and MVPA will have lower BMI, SBP, DBP, RHR, and BF.   
Specific Aim 3:  Examine associations of AT behaviors with CMS risk factors, CMS, and 
physical activity levels among urban, primarily Hispanic women from Arizona. 
 Hypothesis 3a:  Hispanic women who participate in AT will have a lower 
prevalence of abdominal obesity, hypertension, elevated fasting blood 
glucose and triglycerides, low high-density lipoproteins, and CMS, and 
will more frequently meet weekly MVPA recommendations than women 
who do not use active transportation.  
 Hypothesis 3b:  There are beneficial dose-response relationships between 
weekly minutes of AT use and waist circumference, systolic and diastolic 
blood pressures, fasting blood glucose, triglycerides, high-density 
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lipoproteins, CMS risk factor counts, minutes of MVPA per week, and 
total physical activity minutes per day. 
Relationship among Chapters 
 Guided by the EMPA/EMO, specific variables were chosen to address each aim 
for this dissertation.  Aim 1 is addressed in Chapter 2, and was completed to establish the 
state of the science on the association between walking for active transportation, the most 
common method of active transportation, and cardiometabolic health among adults.  The 
desire was to investigate the relationship among women; however, the body of research 
was too limited to include only women, necessitating the inclusion of all adults.  Chapter 
3 provides a secondary analysis to answer Aim 2 and add to the limited active 
transportation research by investigating the relationship between active transportation, 
physical activity, and cardiometabolic health among Hispanic and non-Hispanic black 
women in Texas.  Finally, in Chapter 4 we address Aim 3 through an investigation into 
the association of active transportation with objective measures of cardiometabolic health 
and physical activity, including blood markers among primarily Hispanic women.  
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Figure 1.1.  Model of hypothesized relationships of the Ecological Model of Physical 
Activity/Ecological Model of Obesity being tested. 
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CHAPTER 2 
RELATIONSHIP BETWEEN WALKING FOR ACTIVE TRANSPORTATION AND 
CARDIOMETABOLIC HEALTH AMONG ADULTS: A SYSTEMATIC REVIEW 
It is estimated that over one billion people in the world have cardiometabolic 
syndrome, with total costs into the trillions of dollars (Saklayen, 2018).  Cardiometabolic 
syndrome is a clustering of three of five risk factors, including abdominal obesity, low 
levels of high density lipoproteins, hypertriglyceridemia, elevated fasting blood glucose, 
and hypertension, based on specified diagnostic criteria (Alberti et al., 2009), and can 
increase risks for cancer, cardiovascular disease, stroke, and non-insulin dependent 
diabetes (T2DM) (National Heart Lung and Blood Institute, n.d.).  Cardiovascular disease 
is the number one cause of death across the world with three cardiometabolic risk factors, 
hypertension, T2DM, and dyslipidemia, and physical inactivity identified as the major 
contributing factors (World Health Organization, 2017).   
Moderate to vigorous physical activity participation has numerous health benefits 
documented in the literature, including preventing cardiovascular disease and events, 
preventing, delaying, and treating cardiometabolic syndrome, and decreasing risks for 
T2DM and some cancers (CDC, 2019a; Physical Activity Guidelines Advisory 
Committee, 2018).  Approximately 28% of the global adult population did not meet the 
recommended aerobic guidelines in 2016, with more women (31.7%) than men (23.4%) 
failing to meet guidelines (Guthold, Stevens, Riley, & Bull, 2018).  There are several 
factors that have contributed to high physical inactivity levels, including increased 
sedentary occupations, lack of public space to be active, and increased traffic, air 
pollution, and use of passive methods of travel (World Health Organization, 2019).  
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 The World Health Organization recommends active transportation, walking or 
cycling to or from any destination, as a method to increase physical activity for all 
communities (World Health Organization, 2018).  Active transportation has been found 
to positively be related to decreased risks for diabetes and hypertension (Saunders, Green, 
Petticrew, Steinbach, & Roberts, 2013).  Active transportation to work or school has also 
been found to be associated with better cardiometabolic health, but the review combined 
several cardiovascular outcomes into the synthesis and included both children and adults 
(Xu et al., 2013).  A systematic review with meta-analysis found a significant association 
between active transportation and cardiovascular risk factors; however, when analyzing 
by sex only women had a significant relationship (Hamer & Chida, 2008).  Furthermore, 
hypertension and diabetes were combined with other cardiovascular events and coronary 
heart disease, and were not investigated as individual health outcomes. In the most recent 
systematic review and meta-analysis conducted by Dinu, Pagliai, Macchi, & Sofi (2019), 
active transportation was found to be related to a significant decrease in diabetes, 
cardiovascular disease incidence, all-cause mortality, but not cardiovascular disease or 
cancer mortality.  In subgroup analyses, cycling and walking for active transportation 
were compared and cycling was related to reduced risks for diabetes, cardiovascular 
disease incidence, all-cause and cancer mortality compared to walking.  However, only 
three studies were included with diabetes as the outcome (Dinu et al., 2019), limiting 
interpretability of the findings. 
 Walking for active transportation is more common than cycling (Reynolds et al., 
2014), and walking for physical activity is preferred over any other method among adults 
(CDC, 2013). The previous systematic reviews and meta-analyses on active 
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transportation combined walking and cycling as a single behavior (Hamer & Chida, 
2008; Saunders et al., 2013; Xu et al., 2013), except one (Dinu et al., 2019), making it 
difficult to draw conclusions or make recommendations for walking for active 
transportation alone.  Furthermore, children were included with adults (Xu et al., 2013), 
and none included all five cardiometabolic risk factors separately or cardiometabolic 
syndrome as an outcome.  This demonstrates the need to determine the extent to which 
walking for active transportation is related to improved cardiometabolic risk factors and 
cardiometabolic syndrome among adults, separate from cycling.  It is hypothesized that 
adults who walk for active transportation have better cardiometabolic health than those 
who use passive modes of transportation.  It is expected that as minutes of walking for 
active transportation increase, there will be lower prevalence of cardiometabolic risk 
factors and cardiometabolic syndrome, and/or lower waist circumference, triglycerides, 
fasting blood sugar, blood pressure, number of cardiometabolic risk factors, and higher 
high density lipoproteins. 
Methods 
Protocol 
This systematic review was conducted and reported according to the Preferred 
Reporting Items of Systematic Reviews and Meta-Analyses (PRISMA) (Moher, Liberati, 
Tetzlaff, Altman, & PRISMA Group, 2009) and the protocol has been registered with the 
International prospective register of systematic reviews (PROSPERO); registration 
number CRD42019143081 (https://www.crd.york.ac.uk/prospero/). 
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Data Sources and Search Strategy 
The literature searches for this review were conducted in March of 2019 using 
PubMed, Social Sciences Citation Index, Cochrane Library Trials, CINAHL, and 
PsycInfo.  Databases were searched using advanced-search options, when applicable, 
with an identical search string entered into each, which was active transportation OR 
active commut* OR utilitarian walking OR active travel OR walk* for transportation OR 
walk commut*.  In addition, key terms specific to each database were searched (e.g. 
Transportation/manpower[MeSH Terms]) for PubMed).  The PubMed search was 
restricted by using NOT biological transport, active[MeSH Terms], due to the excessive 
number of studies that were related to biological active transport.  Searches were limited 
to English, but there were no restrictions used for date or country.  Initial searches were 
conducted by one author (EL) and citations were entered into an Excel spreadsheet.  All 
duplicates were removed, and two authors (EL, JS) independently reviewed the final list 
of titles to determine study eligibility for inclusion into the systematic review.  Both 
reviewers also identified previously conducted systematic reviews and meta-analyses 
related to the topic.  The two reviewers compared the selected studies for inclusion and 
discussed any discrepancies.  Additional studies were identified by reviewing the 
reference lists for all studies that met inclusion criteria and any previously conducted 
systematic reviews, and through searches completed for a dissertation literature review.   
Eligibility Criteria 
The inclusion criteria for this review were research studies (a) published in 
English in a peer-reviewed journal, (b) used a randomized-controlled trial, quasi-
experimental, cohort, or cross-sectional research design, (c) investigated and analyzed 
  26 
walking as a method of active transportation in apparently healthy adults (≥ 18 years) 
separately from bicycling, and (d) reported any of the outcomes related to 
cardiometabolic syndrome and/or cardiometabolic risk factors (i.e., blood glucose, blood 
pressure, high density lipoproteins, triglycerides, waist circumference). All conference 
abstracts and studies that analyzed bicycling and walking active transportation together or 
only bicycling for active transportation were excluded. 
Data Extraction 
 All research studies were reviewed multiple times with study characteristics 
extracted and recorded.  The information extracted included (a) study setting, including 
city, state, country (if reported), (b) sample characteristics (size, race, ethnicity, sex, 
mean age), (c) study design, (d) follow-up time period and/or data collection time points, 
(e) measurement of walking for active transportation, (f) dependent variables with 
methods of measurement, (g) covariates (e.g. education, income, physical activity levels), 
(h) description of study findings, and (i) information necessary to conduct a quality 
assessment.   
Quality Assessment 
 The instrument used to assess the quality of included studies was adapted from 
two previously adapted versions of the Strengthening the Reporting of Observational 
Studies in Epidemiology (STROBE) (Lubans, Boreham, Kelly, & Foster, 2011; Wanner 
et al., 2012).  Two reviewers (EL, JS) independently completed the nine-item quality 
assessment for each study to determine a quality score ranging from 0-12, displayed in 
Table 2.1.  Discrepancies between the two reviewers were discussed and disputes were 
resolved with a third reviewer (REL) when necessary.  
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Data Synthesis 
The overall study characteristics and results were synthesized in aggregate.  This 
included (a) study setting, including city, state, country (if reported), (b) sample 
characteristics (size, age, sex, race/ethnicity, socioeconomic status), (c) study design, (d) 
major variables and covariates with methods of measurements, (e) measurement of 
walking for active transportation, (f) follow-up time period and/or data collection time 
points, if applicable, (g) description of significant study findings for each outcome, (h) 
quality assessment rating, (i) strengths, and (j) limitations.   
Results 
Sample 
A total of 13,161 study titles were screened after duplicates were removed.  The 
full text of all studies that included active transportation (or other related term) and any 
health outcome in the title were assessed for eligibility, resulting in 13 studies that met 
inclusion and exclusion criteria and were included in this review.  The flow diagram 
describing study selection can be found in Figure 1.  Of the 13 studies, the designs 
included one pilot randomized controlled trial (Oja et al., 2007), four cohort studies 
(Hayashi et al., 1999; Honda et al., 2015; Kuwahara et al., 2016; Sato et al., 2007), and 
eight cross-sectional studies (Boone-Heinonen et al., 2009; García-Hermoso et al., 2018; 
Larouche, Faulkner, & Tremblay, 2016; Millett et al., 2013; Riiser, Solbraa, Jenum, 
Birkeland, & Andersen, 2018; Tajalli & Hajbabaie, 2017; Tao et al., 2019; Xiao et al., 
2016).  The data collection time points included for the pilot randomized controlled trial 
were at baseline and post 10-week intervention and the range of follow-up for the cohort 
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studies was between 4 and 16 years.  The significance level was set a 0.05 for all 
included studies except one, which was 0.10 (Tajalli & Hajbabaie, 2017). 
Demographic Characteristics 
 The studies were published between 1991 and 2019, with sample sizes ranging 
from 65 to 26,628 and participants aged 18 to 79 years old.  Only one study had fewer 
than 500 participants (Oja et al., 2007).  Eleven studies included samples with both males 
and females (Boone-Heinonen et al., 2009; García-Hermoso et al., 2018; Honda et al., 
2015; Kuwahara et al., 2016; Larouche et al., 2016; Millett et al., 2013; P. Oja et al., 
2007; Riiser et al., 2018; Tajalli & Hajbabaie, 2017; Tao et al., 2019; Xiao et al., 2016) 
and two were only men (Hayashi et al., 1999; Sato et al., 2007). Of the studies with 
samples that included both males and females, only three analyzed the data by sex 
(Boone-Heinonen et al., 2009; García-Hermoso et al., 2018; Xiao et al., 2016).   
Eight different countries were represented in this review.  Four were conducted in 
Japan (Hayashi et al., 1999; Honda et al., 2015; Kuwahara et al., 2016; Sato et al., 2007), 
two each in China (Tao et al., 2019; Xiao et al., 2016) and the United States (Boone-
Heinonen et al., 2009; Tajalli & Hajbabaie, 2017), and one each in Columbia (García-
Hermoso et al., 2018), Canada (Larouche et al., 2016), India (Millett et al., 2013), 
Finland (Oja et al., 2007), and Norway (Riiser et al., 2018).  One study from the United 
States included a sample of white and black participants (Boone-Heinonen et al., 2009), 
and the other did not include race/ethnicity characteristics (Tajalli & Hajbabaie, 2017).  
See Table 2.2 for sample sociodemographic characteristics of each study.  
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Quality Assessment 
 The mean quality score for the included studies was 7.08±1.04 with a range of 
scores from 5 to 8.  The highest possible quality score was 13, demonstrating that the 
included studies were of fairly low quality.   Individual study quality assessment scores 
are found in Table 2.2.   
Over half of the studies were cross-sectional (n = 8) with only 5 longitudinal.  All 
studies included some details related to inclusion/exclusion criteria and/or cited studies 
that provided this information.  Almost 40% of the studies (n = 5) included participants 
that were either randomly selected or population based (Boone-Heinonen et al., 2009; 
García-Hermoso et al., 2018; Larouche et al., 2016; Oja et al., 2007; Tajalli & Hajbabaie, 
2017).  The use and reporting of reliable measures of walking for active transportation 
was only found in four studies (Millett et al., 2013; Riiser et al., 2018; Sato et al., 2007; 
Xiao et al., 2016).  Approximately 46% (n = 6) investigated walking for active 
transportation as a dichotomous variable (Boone-Heinonen et al., 2009; García-Hermoso 
et al., 2018; Oja et al., 2007; Riiser et al., 2018; Tajalli & Hajbabaie, 2017; Xiao et al., 
2016), 46% (n = 6) as a categorical variable (Honda et al., 2015; Kuwahara et al., 2016; 
Larouche et al., 2016; Millett et al., 2013; Sato et al., 2007; Tao et al., 2019), and only 
8% (n = 1) as a continuous (Hayashi et al., 1999) as the highest level of measurement of 
walking for active transportation in the study.  For example, Hayashi et al. (1999) 
investigated walking for active transportation as a continuous variable, but also analyzed 
it as a categorical variable.  Approximately 92% of studies (n = 12) included objective 
measures of outcome variables except for one (Tajalli & Hajbabaie, 2017).  No study 
reported a power analysis; however, 69% of studies (n = 9) had sample sizes ranging 
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from 500-10,000 (Boone-Heinonen et al., 2009; García-Hermoso et al., 2018; Hayashi et 
al., 1999; Larouche et al., 2016; Millett et al., 2013; Riiser et al., 2018; Sato et al., 2007; 
Tajalli & Hajbabaie, 2017; Tao et al., 2019) and almost a quarter (n = 3) had samples 
>10,000 (Honda et al., 2015; Kuwahara et al., 2016; Xiao et al., 2016).  Only 38% of 
studies (n = 5) controlled for age, sex, where applicable, and socioeconomic status 
(Boone-Heinonen et al., 2009; Larouche et al., 2016; Millett et al., 2013; Riiser et al., 
2018; Tajalli & Hajbabaie, 2017). 
Covariates 
 Age (n = 12), other physical activity (n = 11), and smoking (n = 11) were the most 
common covariates found throughout the studies.  There were a total of 58 different 
covariates that were controlled for in the statistical analyses across studies, with a mean 
of 10.15±6.23 covariates per study, which ranged from 0 to 27.  Only five studies 
controlled for age, sex, if applicable, and socioeconomic status.  Table 2.3 includes a 
detailed description of covariates for each study. 
Walking for Active Transportation Measurement  
The levels of measurement and operational definitions for walking active 
transportation can be found for all studies according to outcome in Table 2.4.  Only four 
studies reported the validity and/or reliability for the measure of walking for active 
transportation used in the study (Millett et al., 2013; Riiser et al., 2018; Sato et al., 2007; 
Xiao et al., 2016).  A total of seven studies included a dichotomous variable for walking 
for active transportation with a total of four different operational definitions.  This 
included walking to amenities (Boone-Heinonen et al., 2009), walking to campus 
(García-Hermoso et al., 2018), walking for any active transportation (Riiser et al., 2018) 
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and walking to work (Millett et al., 2013; Tajalli & Hajbabaie, 2017; Tao et al., 2019; 
Xiao et al., 2016).  The comparators included using a car to amenities (Boone-Heinonen 
et al., 2009), non/infrequent walk to campus (García-Hermoso et al., 2018), not working 
or being a farmer (Xiao et al., 2016), no active transportation use (Riiser et al., 2018), 
cycling active transportation (Oja et al., 2007), and using a car (Tajalli & Hajbabaie, 
2017), car/taxi (Tao et al., 2019), or private transport to get to work (Millett et al., 2013).   
In the seven studies that investigated walking for active transportation as a 
categorical variable (Hayashi et al., 1999; Honda et al., 2015; Kuwahara et al., 2016; 
Larouche et al., 2016; Millett et al., 2013; Sato et al., 2007; Tao et al., 2019), there were 
seven different ways that this was operationalized, and these can be found in Table 2.4.  
The reference groups also differed between studies, which included four different 
comparators.  The one study that investigated walking for active transportation as a 
continuous variable defined it as 10 minute increments in walking to work (Hayashi et 
al., 1999).  
Cardiometabolic Health Outcomes 
Data extracted from the studies can be found in Table 2.2, which includes 
significant results.  Details of study characteristics by subgroup can be found in Table 
2.5.  This includes the total number of studies and number significant for walking for 
active transportation measure (dichotomous, categorical, continuous), sex (both, female, 
male), and continent (North America, South America, Europe, Asia) by outcome 
variable. 
Waist circumference/abdominal obesity.  A total of 30.7% (n = 4) of studies 
investigated the association between walking for active transportation and waist 
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circumference/abdominal obesity (Boone-Heinonen et al., 2009; García-Hermoso et al., 
2018; Larouche et al., 2016; Xiao et al., 2016).  Significant associations in the expected 
direction were found in 75% (n = 3) of studies, in which walking for active transportation 
was measured as a dichotomous variable (Boone-Heinonen et al., 2009; García-Hermoso 
et al., 2018; Xiao et al., 2016).  One study found a significant relationship only for men 
(Boone-Heinonen et al., 2009) and another only for women (Xiao et al., 2016).  No dose-
response relationship between walking active transportation and waist 
circumference/abdominal obesity was found (Larouche et al., 2016).   
 High density lipoproteins/low levels of high-density lipoproteins.  Forty-six 
percent (n = 6) of the studies investigated walking active transportation and high density 
lipoproteins/low levels of high density lipoproteins (García-Hermoso et al., 2018; 
Larouche et al., 2016; Oja et al., 2007; Riiser et al., 2018; Tao et al., 2019; Xiao et al., 
2016).  Two found significant relationships in the expected direction (García-Hermoso et 
al., 2018; Tao et al., 2019), with walking for active transportation as a dichotomous 
variable in both.  A significant relationship was found for the entire sample in one study 
(Tao et al., 2019) and only for men in the other (García-Hermoso et al., 2018).  A 
significant dose-response relationship was found for participants who had greater than 30 
minutes of walking active transportation to work compared to car/taxi (Tao et al., 2019). 
 Triglycerides/hypertriglyceridemia.  A total of 46% (n = 6) of included studies 
investigated the relationship between walking for active transportation and high 
triglycerides/hypertriglycerides (García-Hermoso et al., 2018; Larouche et al., 2016; Oja 
et al., 2007; Riiser et al., 2018; Tao et al., 2019; Xiao et al., 2016).  Two studies found an 
association in the expected direction (García-Hermoso et al., 2018; Tao et al., 2019), 
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which investigated walking active transportation as a dichotomous variable.  There were 
no significant relationships when analyzing by sex (García-Hermoso et al., 2018; Xiao et 
al., 2016).  One of two studies (Larouche et al., 2016; Tao et al., 2019) found a significant 
dose-response relationship, where those with greater than 30 minutes of walking active 
transportation to work were less likely to have hypertriglyceridemia compared to those 
who took car/taxi to work (Tao et al., 2019). 
Fasting glucose/type 2 diabetes mellitus.  Almost 62% (n = 8) of studies 
investigated fasting glucose/T2DM (García-Hermoso et al., 2018; Honda et al., 2015; 
Larouche et al., 2016; Millett et al., 2013; Riiser et al., 2018; Sato et al., 2007; Tajalli & 
Hajbabaie, 2017; Xiao et al., 2016).  Three studies found significant associations in the 
expected direction (Millett et al., 2013; Sato et al., 2007; Tajalli & Hajbabaie, 2017), with 
one only significant for urban compared to rural dwellers (Millett et al., 2013).  Two of 
those studies measured walking active transportation as a dichotomous variable (Millett 
et al., 2013; Tajalli & Hajbabaie, 2017).  One significant relationship was found for men, 
which also found those who used walking for active transportation at least 21 minutes to 
work had lower odds of T2DM compared to 10 minutes or fewer (Sato et al., 2007).   
Blood pressure/hypertension.  A little more than half (n = 7) of the studies 
investigated walking active transportation and blood pressure/hypertension (García-
Hermoso et al., 2018; Hayashi et al., 1999; Larouche et al., 2016; Millett et al., 2013; 
Riiser et al., 2018; Tajalli & Hajbabaie, 2017; Xiao et al., 2016).  Just over 57% (n = 4) 
of the studies found a significant relationship in the expected direction (García-Hermoso 
et al., 2018; Hayashi et al., 1999; Riiser et al., 2018; Tajalli & Hajbabaie, 2017), three of 
which the exposure variable was dichotomous (García-Hermoso et al., 2018; Riiser et al., 
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2018; Tajalli & Hajbabaie, 2017).  Riiser et al. (2018) and Tajalli & Hajbabaie (2017) 
found significant relationships for the entire sample and of those that analyzed by sex, 
only men were found to have a significant relationship (García-Hermoso et al., 2018).  
Only Hayashi et al. (1999), with a sample of only men, found a significant dose-response 
relationship where men who walked for active transportation at least 21 minutes to work 
had significantly lower odds of hypertension compared to men who walked for 10 
minutes or less.  Furthermore, for every additional 10 minutes of walking for active 
transportation, the risk of hypertension decreased (Hayashi et al., 1999). 
 Cardiometabolic syndrome.  There was 23% (n = 3) of the studies that 
investigated walking for active transportation and cardiometabolic syndrome (García-
Hermoso et al., 2018; Kuwahara et al., 2016; Xiao et al., 2016).  None of the studies 
demonstrated a significant relationship, either by sex (García-Hermoso et al., 2018; Xiao 
et al., 2016) or for a dose-response (Kuwahara et al., 2016). 
Discussion 
 The purpose of this review was to determine the relationship between walking for 
active transportation with cardiometabolic syndrome risk factors and cardiometabolic 
syndrome among adults.  Walking for active transportation was found to be related to 
smaller waist circumference and/or risk of abdominal obesity (Boone-Heinonen et al., 
2009; García-Hermoso et al., 2018; Xiao et al., 2016) and lower blood pressure and/or 
hypertension prevalence (García-Hermoso et al., 2018; Hayashi et al., 1999; Riiser et al., 
2018; Tajalli & Hajbabaie, 2017); however, this evidence was of fairly low quality.  
Minimal to no evidence was found to suggest a relationship between walking for active 
transportation and high density lipoproteins, triglycerides and/or hypertriglyceridemia, 
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fasting glucose and/or T2DM, or cardiometabolic syndrome.  This review failed to 
demonstrate evidence for dose-response relationships between walking for active 
transportation and any cardiometabolic risk factor.   
 The findings of this review were somewhat unexpected, but not surprising.  There 
were a number of measurement issues revealed among the studies that may have limited 
significant findings, which have been previously identified (Dinu et al., 2019; Hamer & 
Chida, 2008; Saunders et al., 2013; Wanner et al., 2012).  Walking for active 
transportation was inconsistently operationalized, including as a dichotomous, 
categorical, and/or continuous variable.  Walking for active transportation included 
walking to work (Hayashi et al., 1999; Honda et al., 2015; Kuwahara et al., 2016; Millett 
et al., 2013; Tajalli & Hajbabaie, 2017; Tao et al., 2019; Xiao et al., 2016), school 
(García-Hermoso et al., 2018), any neighborhood amenity (Boone-Heinonen et al., 2009), 
and any destination (Larouche et al., 2016; Riiser et al., 2018), with durations ranging 
from zero to 10-minutes, to greater than five hours.  All studies except one (Larouche et 
al., 2016) failed to provide the frequency participants engaged in walking for active 
transportation.   These methodological issues were further compounded by measures of 
walking for active transportation that were self-report and did not report adequate validity 
and/or reliability (Boone-Heinonen et al., 2009; García-Hermoso et al., 2018; Hayashi et 
al., 1999; Honda et al., 2015; Kuwahara et al., 2016; Larouche et al., 2016; Oja et al., 
2007; Tajalli & Hajbabaie, 2017; Tao et al., 2019).   
These rudimentary measures of active transportation are consistent throughout the 
literature and have been recognized as a methodological issue for over a decade (Hamer 
& Chida, 2008; Shephard, 2008), yet the use of flawed measures persist in the most 
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current research conducted (García-Hermoso et al., 2018; Larouche et al., 2016; Tajalli & 
Hajbabaie, 2017; Tao et al., 2019).  The inconsistency between measures and issues 
inherent with subjective measures making it difficult to detect significant relationships, 
draw conclusions, and/or conduct a quantitative analysis.  It is vital that future research 
incorporate valid and reliable objective measures of walking for active transportation that 
can delineate destination, mode of transportation/activity, frequency, and duration.  This 
could include using a combination of accelerometers and global positioning systems 
(Carlson et al., 2015); however, these measures are somewhat prohibitive due to cost, 
skills to analyze these types of data, and the perception of an invasion of privacy by 
research participants.  Further research should be conducted to develop an objective 
measure of walking for active transportation that is affordable that can be analyzed easily 
to maximize use. 
There were significant design and statistical heterogeneity investigating each 
cardiometabolic health outcome among the included studies, which can be found in 
Table 2.4.  This demonstrated the wide range of exposure criteria for active 
transportation, comparators, abnormal cut-points for outcome variables, and statistical 
tests between studies (Althuis, Weed, & Frankenfeld, 2014).  It was determined that the 
interpretability of any meta-analysis would have been difficult and inappropriate; 
therefore, was not conducted (Borenstein, Hedges, Higgins, & Rothstein, 2009). 
 Physiological responses, or lack thereof, between walking for active 
transportation and cardiometabolic health may partially explain the findings in this 
review, especially because the included studies failed to quantify the duration or intensity 
of walking for active transportation.  Previous research has demonstrated that longer 
  37 
durations of physical activity may be needed to significantly improve high density 
lipoproteins and triglycerides in adults (Kodama et al., 2007; Pedersen & Saltin, 2015), 
suggesting that it takes a minimum of 120 minutes of physical activity per week to 
improve high density lipoproteins (Pedersen & Saltin, 2015).  A systematic review with 
meta-analysis and meta-regression analysis of walking interventions found that walking 
significantly improved fasting glucose and blood pressure, but not waist circumference, 
high density lipoproteins, or triglycerides.  Furthermore, the only dose-response 
improvements found for any cardiometabolic risk factor was between session duration 
and systolic blood pressure (Oja et al., 2018), suggesting that walking for active 
transportation may not be long or intense enough to impact cardiometabolic risk factors, 
especially the blood markers.   
There may also be physiological differences based on sex.  We found a significant 
association in the expected direction found for women only 7.7% of the time (Xiao et al., 
2016) compared to 33.3% for men (Boone-Heinonen et al., 2009; García-Hermoso et al., 
2018; Hayashi et al., 1999; Sato et al., 2007).  Only a few studies in this review were 
analyzed by sex, which could obscure significant relationships if there different 
physiological responses to walking for active transportation based on sex.  Contrary to 
our findings, Hamer & Chida (2008) found more protective effects between active 
transportation and cardiovascular risk for women than men; however, Dinu et al. (2019) 
and Wanner et al., (2012) found no differences in any outcome by sex.  Research 
investigating the effects of physical activity on cardiometabolic outcomes has been 
unable to draw sex-specific conclusions, because the literature is either inconsistent 
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and/or inconclusive (Oja et al., 2018; Physical Activity Guidelines Advisory Committee, 
2018; Zhang et al., 2017).   
Finally, few studies exist that investigate walking for active transportation and 
cardiometabolic risk factors and syndrome.  Most of the research found included cross-
sectional and cohort designs, with only one experimental study.  Considering the limited 
quantity of studies combined with the extensive methodological quality issues, it is 
difficult to draw firm conclusions.  It is imperative that future research be conducted with 
experimental designs to determine the presence of any causal relationships between 
walking for active transportation and cardiometabolic health, using objective exposure 
and outcome measures.  This should include large samples of diverse populations and be 
analyzed by sex to determine any differences in effects.     
Strengths and Limitations 
 To our knowledge, this is the first systematic review specifically investigating 
walking for active transportation and cardiometabolic health among adults.  We identified 
measurement and methodological issues, as well as gaps in the literature that provide 
direction for future research to improve study quality.  The main limitation to this review 
was the inability to conduct a meta-analysis for each cardiometabolic outcome.   
Conclusion 
 The evidence-base for walking for active transportation is of low quality and 
primarily cross-sectional and cohort designs, with weak measures of walking for active 
transportation.  Future research should include randomized controlled trials using 
objective measures of walking for active transportation to determine the causal effects on 
cardiometabolic health.  Study designs need to include consistent definitions and 
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measurements of walking for active transportation, with analyses conducted by sex. 
Walking for active transportation may influence waist circumference and blood pressure 
among adults warranting further investigation.  Policymakers and city planners should 
incorporate pedestrian friendly options into existing and proposed zoning and 
infrastructure designs, and health practitioners should encourage patients to participate in 
walking active transportation, when appropriate.   
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Figure 2.1.  Flow diagram of study selection.   
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CHAPTER 3 
HEALTH IS POWER (HIP): ACTIVE TRANSPORTATION, PHYSICAL ACTIVITY, 
AND CARDIOMETABOLIC HEALTH AMONG ETHNIC MINORITY WOMEN 
Abstract 
Background:  Active transportation (AT) increases physical activity (PA), reducing 
cardiometabolic risk among non-Hispanic white adults; however, research on these 
linkages in racial/ethnic minority women is sparse.  This study explored these 
associations in 327 African American (AA) and Hispanic/Latina (HL) women. Methods:  
This analysis used sociodemographics, self-reported AT via the International Physical 
Activity Questionnaire, accelerometer-measured moderate to vigorous PA (MVPA), body 
mass index (BMI), systolic (SBP) and diastolic blood pressures (DBP), resting heart rate 
(RHR), and body fat percentage (BF).  Unadjusted bivariate associations and associations 
adjusted for sociodemographic demographic factors were examined.  Results: AT users 
had higher levels of objective MVPA, but this was not statistically significant. AT was 
not associated with cardiometabolic risk factors in adjusted models (ps>.05); however, 
SBP was lower for AT users. MVPA was negatively associated with DBP and BF 
overall, negatively associated with BMI and BF in AA women, and negatively associated 
with BF in HL women (ps<.05).  Conclusions:  MVPA was associated with 
improvements in BMI, DBP, and BF among minority women, and these relationships 
may vary by race/ethnicity. Practitioners should recommend increased participation in 
MVPA.  Future research, using longitudinal designs, should investigate AT’s potential 
for increasing MVPA and improving cardiometabolic health along with the role of 
race/ethnicity in these associations.    
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In 2017, only 24% of adults in the United States met the 2008 physical activity 
recommendations (Blackwell & Villarroel M.A., 2018). African American and 
Hispanic/Latina women were less likely (13.9% and 13.8%, respectively) to have met 
recommendations than non-Hispanic white women (23.7%) were.  Despite the many 
health promoting benefits physical activity has for adults, including prevention and 
control of excessive weight gain, type 2 diabetes mellitus, hypertension, dyslipidemia, 
and/or cardiometabolic syndrome (Physical Activity Guidelines Advisory Committee, 
2018), low rates of physical activity participation persist among women of color.   
In the United States, healthcare costs for an individual with cardiometabolic 
syndrome are approximately $4,000 per year higher than costs for an individual without 
cardiometabolic syndrome (McQueen et al., 2016).  A cardiometabolic syndrome 
diagnosis includes having been diagnosed with at least three of the following risk factors: 
hypertension, abdominal obesity, low levels of high-density lipoproteins, 
hypertriglyceridemia, and pre-diabetes (National Heart Lung and Blood Institute, n.d.).  
Across all adult age groups, racial/ethnic minority women are disproportionately affected 
by cardiometabolic syndrome compared to non-Hispanic white women, with prevalence 
of cardiometabolic syndrome exceeding 50% among African American and 
Hispanic/Latina women age 50 or older (Moore et al., 2017).  
Active transportation is walking or bicycling for all or part of a commute to any 
destination (CDC, 2011).  Systematic reviews conducted to evaluate active transportation 
use and health have found active transportation to be associated with a lower risk of 
diabetes and high blood pressure (Berger, Qian, & Pereira, 2017; Furie & Desai, 2012; 
Saunders et al., 2013; Xu et al., 2013) and lower body weight in adults (Wanner et al., 
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2012; Xu et al., 2013).  Furthermore, active transportation users have been found to have 
better cardiovascular health than those who do not use active transportation (Xu et al., 
2013), suggesting that promotion of active transportation may be an effective physical 
activity intervention.  Active transportation may provide a sustainable method to improve 
health and reduce cardiometabolic syndrome in racial/ethnic minority women, because it 
is accessible (low cost, not requiring additional equipment) and does not require taking 
time away from family, which has been found to be a barrier to physical activity (Bautista 
et al., 2011; Im et al., 2010).  Incorporating active transportation into a daily trip to work, 
school, or other destination can add numerous opportunities to be active every day and 
allows members of the family to participate in the activity together. 
Participation in health promoting behaviors, such as physical activity and active 
transportation, is complex and multiply determined.  The Ecological Model of Physical 
Activity (EMPA) is a dynamic systems framework used to guide investigation into how 
factors at multiple (e.g., micro and macro) environmental levels can act directly and 
indirectly, and interact within and across people and places to influence individual-level 
physical activity (including active transportation) and health outcomes (Lee et al., 2015; 
Lee & Cubbin, 2009; Spence & Lee, 2003). This framework allows for exploration of 
how social and economic factors, such as income, education, and cultural context may 
influence individual participation in health promoting behaviors and, in turn, health 
outcomes.  
Although numerous studies have investigated the health promoting benefits of 
active transportation in samples of primarily white adults (Furie & Desai, 2012; Laverty, 
Mindell, Webb, & Millett, 2013; Saunders et al., 2013; Wanner et al., 2012; Xu et al., 
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2013), these associations have not been well-studied in African American or 
Hispanic/Latina women.  Furthermore, the current literature on how best to provide 
effective physical activity interventions and recommendations for different social groups 
and minority women is still sparse (Ball, Carver, Downing, Jackson, & O’Rourke, 2015; 
Physical Activity Guidelines Advisory Committee, 2018).  Guided by the EMPA, this 
exploratory study addresses this gap in the literature by investigating associations among 
active transportation, physical activity, and cardiometabolic risk factors in a sample of 
African American and Hispanic/Latina women from two large cities in Texas, and 
examines these associations by race/ethnicity.  We hypothesized that women who used 
active transportation would have lower body mass index (BMI), systolic (SBP) and 
diastolic blood pressure (DBP), resting heart rate (RHR), and body fat percentage (BF) 
than women who did not use active transportation.  It was also expected that time spent in 
active transportation and MVPA, would be negatively associated with BMI, SBP, DBP, 
RHR, and BF.   
Methods 
Data Source 
This study was a secondary analysis of data collected as part of the Health is 
Power (HIP) study, a longitudinal, multi-site, randomized controlled trial conducted in 
Houston and Austin, Texas between 2006-2008 to increase physical activity or fruit and 
vegetable consumption among racial/ethnic minority women (1R01CA109403).  
Participants completed interviewer-administered surveys at baseline health assessments 
(Lee et al., 2011; Lee et al., 2011)  Study assessments, measures, and procedures were 
approved by the Committee for the Protection of Human Subjects at the University of 
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Houston and the Institutional Review Board at the University of Texas, Austin and 
informed consent was obtained by all study participants.     
Participants 
Physically inactive, non-pregnant women who identified as African American or 
Hispanic/Latina, aged 25 to 60 years old, and who were able to read and write in English 
or Spanish were recruited to participate in the study.  Details of study eligibility, 
recruitment, and intervention have been previously published (Lee et al., 2011; Lee et al., 
2011).  A total of 410 participants provided written informed consent and were enrolled 
in the study.  Only participants who completed the self-reported measure of active 
transportation at baseline were included in this secondary analysis. 
Individual Measures 
Sociodemographic variables.  Sociodemographic variables included 
race/ethnicity, age, educational attainment, and household income adjusted for number of 
family members. These were collected using an adapted version of the Maternal Infant 
Health Assessment survey, which has been previously used with diverse populations 
(California Department of Public Health, 2010). 
Active transportation and physical activity.  Active transportation and physical 
activity were measured using items from the long form of the International Physical 
Activity Questionnaire (IPAQ).  The IPAQ has established reliability (0.80) but fairly low 
validity (0.30), consistent with other self-reported measures of physical activity (Craig et 
al., 2003).  The IPAQ questionnaire allows for calculation of total physical activity in 
MET-minutes per week, a measure of frequency and intensity of exercise, and time spent 
in different domains of physical activity, including transportation, work, domestic, and 
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leisure-time activity, as well as time spent engaging in moderate and vigorous intensity 
physical activity across all domains (Craig et al., 2003; Sjöström, Bull, & Craig, 2002).  
Active transportation was operationalized using two methods to answer our hypotheses.  
Time spent in active transportation was dichotomized into active transportation user (any 
IPAQ transportation-related physical activity) versus no active transportation use (no 
IPAQ transportation-related physical activity).  In addition, IPAQ transport-related MET-
minutes per week were used as a continuous variable for active transportation.  MET-
minutes per week spent in (a) moderate physical activity, (b) vigorous physical activity, 
(c) combined moderate-to-vigorous physical activity (MVPA), (d) total physical activity, 
(e) total physical activity minus active transportation, and (f) MET-minutes per day of 
MVPA were used in the analyses.  Self-reported total IPAQ physical activity values of 
greater than 960 MET-minutes per day were excluded from the analyses based on the 
IPAQ scoring protocol’s data processing rules (IPAQ Research Committee, 2005).  
Objective moderate vigorous physical activity.  Objective MVPA was 
measured using unidirectional ActiGraph GT1M accelerometers (ActiGraph, Pensacola, 
Florida) (ActiGraph, n.d.), which has demonstrated reliability with an intraclass 
correlation of 0.87 (Welk, 2005).  During baseline health assessments, a subsample of 
participants from the Houston site was asked to wear the accelerometer for seven days, 
taking it off for sleeping or bathing, and to record daily wear times on an accelerometer 
log.  Accelerometers were not available at the Austin site.  After seven days, participants 
returned accelerometers, and all data were downloaded and processed as previously 
described (Layne, Mama, Banda, & Lee, 2011), with MVPA minutes per day used in the 
analyses. 
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Cardiometabolic risk factors.  BMI, SBP, DBP, RHR, and BF were measured or 
derived from measures collected at baseline.  Each anthropometric feature (height, 
weight, and BF) was measured twice using established protocols by trained research staff, 
and the average of the two measurements was computed (Lee et al., 2011).  Height was 
measured in inches using a stadiometer for use in the calculation of BMI.  Weight and BF 
were measured using the Tanita Body Fat 310 scale (Tanita, Arlington Heights, IL) in 
pounds (Kueht, McFarlin, & Lee, 2009; Lee et al., 2011).  RHR was measured by 
palpating the radial pulse and counting for one full minute, after the participant had sat 
quietly in a chair for two minutes.  SBP and DBP were also measured twice and averaged 
using a manual aneroid sphygmomanometer on the left arm with two minutes between 
measurements, following detailed protocols previously published (Lee, Mama, & 
Adamus-Leach, 2012; Lee, Mama, & Lopez III, 2012). 
Statistical Analyses 
Descriptive analyses were used to summarize sociodemographic characteristics 
(race/ethnicity, site, education, household income adjusted for family size, age). Chi-
square tests, Fisher’s exact tests (for expected frequencies less than 5), and independent 
samples t-tests were used to examine bivariate associations of active transportation use 
(any/none) and race/ethnicity (African American and Hispanic/Latina) with 
sociodemographic variables, cardiometabolic risk factors (BMI, BF, RHR, SBP, and 
DBP), and physical activity measures (IPAQ-measured moderate, vigorous, and total 
physical activity and MVPA; accelerometer-measured MVPA). Bivariate correlations 
among active transportation use, physical activity measures, and cardiometabolic risk 
factors were computed for the full sample and separately by race/ethnicity.   
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Separate linear regression models were used to estimate the association between 
active transportation use and each cardiometabolic risk factor, and the relationship 
between MET-minutes of active transportation each cardiometabolic risk factor, adjusting 
for covariates (sociodemographic variables and total IPAQ physical activity minus active 
transportation). Associations between accelerometer-measured MVPA and 
cardiometabolic risk factors were also estimated, adjusting for sociodemographic 
variables. Finally, regression models were used to examine associations of dichotomous 
active transportation use, MET-minutes of active transportation, and accelerometer-
measured MVPA with each of the cardiometabolic risk factors separately by 
race/ethnicity (African American and Hispanic/Latina), adjusting for income, education 
and age. Site was not included as a covariate as it was perfectly collinear with 
race/ethnicity. All analyses were conducted using SPSS version 23.0 with the 
significance level set at 0.05. 
Results 
Of the 410 participants enrolled in the study, 367 completed the IPAQ. Of those, 
40 participants reported greater than 960 minutes per day of total physical activity and 
were excluded from analyses (IPAQ Research Committee, 2005), yielding a total analytic 
sample of 327 participants.  Participants excluded from analyses were significantly more 
likely to be African American (vs. Hispanic/Latina) than those whose data were retained 
for analysis, χ2 (1, N = 410) = 6.49, p < .05.  Exclusion (vs. inclusion) was not 
significantly related to site, income, education level, age, or any cardiometabolic risk 
factor (ps > .05).  Due to accelerometry data only being collected at the Houston site, a 
higher proportion of participants with valid accelerometer data (n = 159) were African 
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American (n = 103) compared to Hispanic/Latina (n = 56), but sociodemographic 
characteristics or outcome variables from participants with accelerometer data were not 
significantly different from those without (n = 168).  
Participant Characteristics 
Demographic characteristics for the entire sample, and by active transportation 
use and race/ethnicity are described in Table 3.1.  The means and standard deviations of 
cardiometabolic risk factors and physical activity measures for the total sample, active 
transportation users versus non-users, and African American versus Hispanic/Latina 
women are presented in Table 3.2.   
There were no significant differences in cardiometabolic risk factors or physical 
activity measures by education.  Women who reported an income of 101-200% of the 
federal poverty level (FPL) self-reported significantly higher amounts of total IPAQ 
physical activity compared to women with an income of 201-300% of the FPL (M = 
2173.29, SD = 1873.25 vs. M = 1203.03, SD = 1325.58, respectively; F[4, 302] = 2.62, p 
< .05).  There were no differences in outcome variables by income or site.   
Meeting Physical Activity Guidelines 
Self-reported physical activity for the overall sample was high, with the majority 
(62.4%) reporting achieving the minimum recommended guidelines of at least 500 MET-
minutes per week of total physical activity.  Active transportation users were significantly 
more likely to report meeting physical activity guidelines than were non-users (88.2% vs. 
69.6%; χ2 (1, n = 327) = 15.70, p < .001).  There were no significant differences in 
meeting weekly IPAQ physical activity recommendations for African American women 
compared to Hispanic/Latina women (60.0% vs. 67.0%; χ2 (1, n = 327) = 1.52, p > .05).  
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Of the 159 participants with accelerometer-measured MVPA, 32.1% (n = 51) met the 
national MVPA recommendation of 150 minutes per week.  A higher percentage of 
active transportation users also met MVPA recommendations than non-users (35.8% vs. 
29.3%); however, this difference was not significant (χ2 (1, n = 159) = 0.746, p > .05).  
Significantly more African American women (44.7%) met the recommendation 
compared to Hispanic/Latina women (8.9%; χ2 (1, n = 159) = 21.26, p < .001).   
Bivariate Correlations 
Age was significantly correlated with SBP (r = .33; p < .001), DBP (r = .23; p < 
.001), BF (r = .18; p < .01), moderate IPAQ physical activity (r = .13; p < .05), and total 
IPAQ physical activity (r = .11; p < .05) for the sample.  Table 3.3 presents bivariate 
correlations of active transportation use, physical activity measures, and cardiometabolic 
risk factors.  Tables 3.4 and 3.5 present bivariate correlations of active transportation use, 
physical activity measures, and cardiometabolic risk factors for African American and 
Hispanic/Latina women in the sample, respectively. 
Linear Regression Models 
Active transportation predicting cardiometabolic risk. In linear regression 
models adjusting for demographic variables (race/ethnicity, site, income, education, age) 
and non-active transportation physical activity, active transportation use (any/none) and 
MET-minutes of active transportation were not significantly associated with BMI, SBP, 
DBP, RHR, or BF (ps > .05) for the full sample.  Likewise, in analyses conducted 
separately in African American-only and Hispanic/Latina-only subsamples, active 
transportation use and MET-minutes of active transportation were not associated with 
BMI, SBP, DBP, RHR, or BF for either group (ps > .05).   
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Accelerometer-measured MVPA predicting cardiometabolic risk. In models 
of linear associations between accelerometer-measured MVPA and individual 
cardiometabolic risk factors (adjusting for race/ethnicity, site, income, education, and 
age), MVPA was negatively associated with DBP (b = -0.074, t = -1.98, p = .052) and BF 
(b = -0.094, t = -3.22, p < .01).  Associations between accelerometer-measured MVPA 
and BMI, SBP, and RHR were not significant (ps > .05).  
For African American women, accelerometer-measured MVPA was significantly 
inversely associated to BMI (b = -0.097, t = -2.65, p < .05) and BF (b = -0.081, t = -2.69, 
p < .01), but not SBP, DBP, or RHR (ps > .05).  Among Hispanic/Latina women, BF was 
the only risk factor significantly related to accelerometer-measured MVPA (b = -0.292, t 
= -2.79, p < .01) after controlling for income, education, and age.   
Discussion 
The purpose of this study was to investigate relationships among active 
transportation, MVPA, and cardiometabolic risk factors among African American and 
Hispanic/Latina women. This is the first observational study to examine the relationship 
between active transportation use and cardiometabolic risk factors among racial/ethnic 
minority women, while also investigating outcomes based on race/ethnicity.  The results 
of this secondary analysis did not provide support for the hypothesis that active 
transportation use is associated with better cardiometabolic health in this sample of 
women; however, SBP was found to be slightly lower, albeit not significantly so, among 
the women using active transportation compared to those who did not.  Analyses showed 
no relationship between active transportation use and cardiometabolic risk factors by 
race/ethnicity.  Accelerometer-measured MVPA was found to be inversely related to 
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DBP and BF for the entire sample, consistent with current literature (Physical Activity 
Guidelines Advisory Committee, 2018), but not related to BMI, SBP, or RHR.  Further 
analyses by race/ethnicity revealed that accelerometer-measured MVPA was only 
associated with lower BMI and BF among African American women, and lower BF for 
Hispanic/Latina women.   
The findings of this study are contrary to systematic reviews, which found active 
transportation use to be inversely associated with body weight (Wanner et al., 2012; Xu 
et al., 2013) and blood pressure (Furie & Desai, 2012; Saunders et al., 2013) among 
adults. Additionally, walking and cycling as modes of active transportation have been 
found to be related to improved cardiovascular health including lower total cholesterol, 
and low-density lipoproteins, increased high-density lipoproteins, and improved blood 
glucose levels (Xu et al., 2013).  According to one review (Saunders et al., 2013), those 
who used active transportation for relatively longer distances had a lower risk of type 2 
diabetes mellitus and hypertension; however, an actual dose-response relationship could 
not be clearly ascertained due to the inconsistencies across the studies in the 
measurement of time spent in, and intensity of, active transportation.  For example, 
studies differed in how they classified an individual as an active transportation user 
versus non-active transportation user, with an active transportation user defined as 
someone spending greater than 20 minutes, greater than 30 minutes, 3 MET-hours, or 8 
MET-hours in active transportation per day. Furthermore, the intensity of active 
transportation, as influenced by factors such as terrain, climate, or traffic congestion, was 
not reported in any of the papers reviewed (Saunders et al., 2013).  Given that the typical 
intensity level of AT-related physical activity in previous studies is unknown and that 
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there is no way of determining intensity level in the data reported herein, directly 
comparing our findings to those of previous studies is impossible.  This could also 
explain the absence of a significant relationship between active transportation and 
cardiometabolic health. 
The active transportation users in this sample of African American and 
Hispanic/Latina women reported significantly more self-reported total physical activity 
per week compared to non-active transportation users, suggesting that active 
transportation may help women increase their weekly physical activity, as others have 
also suggested (Physical Activity Guidelines Advisory Committee, 2018; Whitfield, Paul, 
& Wendel, 2015).  Women reported participating in just over 300 MET-minutes of active 
transportation per week, meeting over half the minimum weekly physical activity 
recommendations with active transportation alone.  The overall sample self-reported 
participating in large amounts of weekly physical activity (1,718 MET-minutes) and 
MVPA (1,211 MET-minutes), which is higher than national trends for this population 
(Blackwell & Villarroel M.A., 2018).  This discrepancy may reflect overestimation of 
physical activity, a bias commonly found in self-reported physical activity data. 
Interestingly, Hispanic/Latina women self-reported higher levels of moderate and 
vigorous physical activity than African American; however, accelerometry demonstrated 
African American women actually had significantly higher levels of MVPA. This is 
consistent with literature that suggests age may moderate self-report bias in 
Hispanic/Latina women (Nicaise, Marshall, & Ainsworth, 2011).  Overall, objectively 
measured MVPA levels were lower than self-reported MVPA levels.  Nevertheless, the 
objectively measured MVPA was somewhat higher for active transportation users than 
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non- active transportation users, lending some support to findings from the self-reported 
data showing higher rates of physical activity among active transportation users.  
This sample engaged in approximately 133 minutes of accelerometer-measured 
MVPA per week, which is just below the weekly aerobic recommendation of 150 
minutes of MVPA to maintain and/or improve health (Physical Activity Guidelines 
Advisory Committee, 2018); however, greater MVPA minutes were only related to 
improvements in DBP and BF in this sample.  When examining associations by 
race/ethnicity, accelerometer-measured MVPA and DBP were no longer significantly 
related, but associations with BMI became significant.  African American women 
achieved a mean of 177 minutes of objective MVPA per week, surpassing the 
recommended weekly MVPA guidelines. This was associated with BMI and BF, but not 
SBP, DBP, or RHR.  Hispanic/Latina women participated in only approximately 66 
minutes of MVPA per week, and for them, MVPA was negatively related to BF.   
When considering the findings of the study through the lens of the EMPA, the 
linkages between race/ethnicity, education, MVPA participation, and cardiometabolic 
outcomes are complex. The African American women in this sample had significantly 
more education than the Hispanic/Latina women and, as expected, the African American 
women participated in significantly more accelerometer-measured MVPA.  It was also 
expected that the higher levels of MVPA would have translated to better health outcomes, 
though this was only consistent with BMI and BF.  Furthermore, African American 
women actually had higher SBP, DBP, and BF than the Hispanic/Latina women in this 
sample, and, although this difference was not statistically significant, it is clinically 
significant, especially related to SBP.  The sample mean for SBP of the African 
  74 
American women was 126.08 mmHg compared to 123.18 for Hispanic/Latina women, 
increasing their risks for all-cause and cardiovascular disease mortality, coronary heart 
disease, and cardiovascular disease (Bundy et al., 2017).  Consistent with the EMPA, this 
may suggest there are other cultural and/or biological factors that may moderate the 
effects of MVPA on cardiometabolic health in racial/ethnic minority women 
necessitating further investigation (Lee et al., 2015; Lee & Cubbin, 2009; Spence & Lee, 
2003). 
Strengths and Limitations 
This is the first study investigating the associations between active transportation 
use and cardiometabolic risk factors in a large sample of racial/ethnic minority women, a 
population that has been underrepresented in active transportation and physical activity 
research (Furie & Desai, 2012; Physical Activity Guidelines Advisory Committee, 2018; 
Saunders et al., 2013; Wanner et al., 2012; Xu et al., 2013).  The IPAQ has been shown 
to be reliable in diverse populations (Craig et al., 2003), and the addition of 
accelerometer-measured physical activity is a strength of this study. All cardiometabolic 
measures were objectively measured by trained research staff. History of hypertension or 
antihypertensive medication status was not recorded at the time of measurement; 
however, women with untreated hypertension were excluded from the study following 
the PAR-Q protocol.  One caveat of this study is that the education and income levels of 
the study participants were quite high, limiting generalizability and negatively 
influencing active transportation participation rates (Lee, Lorenzo, Heck, Kohl III, & 
Cubbin, 2017).  A majority of the sample was obese with elevated SBP, which could 
potentially limit the ability to detect differences and associations related to those 
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outcomes.  Self-report measures may have been biased by overestimation or social 
desirability.  As these data were collected using correlational cross-sectional design; 
causation may not be inferred. 
Future research should continue to examine this relationship using objectively 
measured active transportation and physical activity, as well as active transportation 
intensity, using longitudinal designs to determine the presence and magnitude of a 
potential dose-response relationship between active transportation use and MVPA on 
cardiometabolic risk factors among racial/ethnic minority women. Further investigation 
into the relationship between active transportation use and additional cardiometabolic risk 
outcomes, including fasting blood glucose, triglycerides, and high-density lipoproteins is 
recommended.  Health practitioners should, when appropriate, encourage patients to 
substitute active transportation for any daily motorized transport to increase levels of 
MVPA. Policymakers should develop and pass policies that increase safe and pleasant 
routes to destinations for active commuters and walkability of the built environment to 
promote active transportation use to potentially increase overall MVPA levels.   
Conclusion 
 Active transportation use has been found to be associated with improved 
cardiometabolic health in the literature; however, this investigation did not show a 
significant relationship between active transportation and cardiometabolic risk factors in 
this sample of women.  Objectively measured MVPA was associated with more favorable 
DBP, BMI, and BF values; therefore, health practitioners should recommend to their 
African American and Hispanic/Latina women patients that they increase overall MVPA 
levels to improve cardiometabolic risk factors and promote health.  Active transportation 
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appears to be a good strategy for racial/ethnic minority women to increase their daily 
physical activity levels; however, more research is needed to determine the 
cardiometabolic health benefits of active transportation, including at different intensity 
levels.  African American women who meet national weekly aerobic physical activity 
recommendations may not see improvements in health outcomes, necessitating research 
to determine the amount and types (e.g., aerobic, strength training, flexibility) of physical 
activity needed to result in improved health outcomes in this population.  
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CHAPTER 4 
LINKING ACTIVE TRANSPORTATION USE AND CARDIOMETABOLIC RISK 
FACTORS AMONG PRIMARILY HISPANIC AND LATINA MOTHERS 
Physical inactivity has an economic impact of approximately 117 billion dollars 
per year in the United States (CDC, 2019a).  The benefits of regular participation in 
moderate to vigorous physical activity (MVPA) have been well documented in the 
literature, including decreasing risks for cancer, non-insulin dependent diabetes (T2DM), 
cardiovascular disease, and stroke.  MVPA is also an effective method to prevent, treat, 
and/or delay cardiometabolic syndrome (CMS) among adults (CDC, 2019a; Physical 
Activity Guidelines Advisory Committee, 2018).   
CMS consists of a cluster of preventable risk factors that significantly increases 
morbidity and mortality.  According to the National Cholesterol Education Program 
Adult Treatment Panel III (ATP III) diagnostic criteria, CMS is defined as having three 
of five risk factors, which include hypertension (HTN), abdominal obesity, elevated 
fasting blood glucose (FG), high triglycerides (TG), or low high-density lipoproteins 
(HDL) (Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol 
in Adults, 2001; Grundy et al., 2005).  CMS increases risks for T2DM, cancer, coronary 
heart disease, and stroke, which can have a detrimental effect on quality of life and 
healthcare costs (National Heart Lung and Blood Institute, n.d.).   
Hispanic/Latina (HL) women are disproportionally affected by negative health 
outcomes and low participation in physical activity compared to non-HL white women.  
Across all age groups, HL women have a higher prevalence of CMS than non-HL white 
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women (Moore et al., 2017).  Additionally, HL women have much lower rates of meeting 
the recommended physical activity guidelines (13.8%) than non-HL white women 
(23.7%).  Cultural family obligations (D’Alonzo, 2012; Gil & Vazquez, 2014) and 
limited time available often prevent HL women from regularly participating in physical 
activity away from their families (Bautista et al., 2011; Mama et al., 2015).   
Active transportation, walking or cycling as a mode of transport, may provide a 
sustainable solution for HL women to participate in physical activity because family 
members can participate in active transportation together.  This would allow HL women 
to overcome some of the barriers that keep them from regular physical activity.  Active 
transportation has been found to be associated with better cardiovascular health (Dinu et 
al., 2019; Hamer & Chida, 2008), lower risks for T2DM (Dinu et al., 2019; Furie & 
Desai, 2012; Saunders et al., 2013), lower body weight (Xu et al., 2013), and higher 
overall levels of physical activity (Wanner et al., 2012).  Studies investigating the 
relationship between active transportation and cardiometabolic health and/or physical 
activity have been conducted primarily with non-HL white adults and have not 
consistently conducted subgroup analyses based on gender and/or ethnicity.   
The purpose of this study is to examine associations of active transportation with 
CMS risk factors, CMS, and physical activity levels among urban-dwelling, primarily HL 
women from Arizona.  We hypothesized that women who use active transportation will 
have lower prevalence rates of HTN, abdominal obesity, elevated FG, high TG, low 
HDL, and CMS, and will more frequently meet weekly MVPA recommendations than 
women who do not use active transportation.  Additionally, those engaging in more 
minutes of active transportation per week will have relatively lower systolic (SBP) and 
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diastolic blood pressure (DBP), waist circumference (WC), FG, TG, and CMS risk factor 
counts, while their HDL, minutes of MVPA per week, and minutes of total physical 
activity per day will be relatively higher. 
Methods 
Participants 
Participants were recruited from nine early care and education centers (ECEC) 
that were enrolled in cohort two of the “Partnering for Early Childhood Physical 
Activity:  Sustainability via Active Garden Education (SAGE)” cooperative agreement 
research project (PI: Lee; U01MD010667) in Phoenix, Arizona.  SAGE is a cluster-
randomized controlled, crossover trial to determine the efficacy of a garden-based 
curriculum developed to increase physical activity and fruit and vegetable consumption 
of children aged 3-4 years.  Details of the SAGE intervention and ECEC recruitment 
procedures have been published elsewhere (Lee et al., 2019).   
Female guardians who enrolled in SAGE and provided informed consent were 
asked to participate in this study if they met inclusion and exclusion criteria.  The 
inclusion criteria were being able to speak, read, and write in English or Spanish.  
Exclusion criteria were being pregnant, fewer than 3 months postpartum, or diagnosed 
with type 1 diabetes mellitus.  All eligible participants were asked to provide a fasting 
blood sample with point of care testing (POCT) at the time of informed consent at 
morning recruitment, if fasting for at least eight hours, or at a scheduled morning 
appointment at their child’s ECEC.  All participants were given a $10 incentive after 
completion.  The Institutional Review Board at Arizona State University approved all 
procedures of the study. 
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Individual Measures 
The data presented here were collected at the SAGE Cohort 2 baseline assessment 
and at the time of POCT, between August and October 2018, via questionnaires provided 
in either English or Spanish and in either paper or online format, depending on 
participant’s preferences.  The survey questions completed at POCT were interviewer-
administered and asked in either English or Spanish.  These additional questions were 
used to verify exclusion criteria and active transportation use at the time of POCT, due to 
lower than expected rates of return for baseline data and to ensure active transportation 
was captured for all participants that underwent point of care testing, which was the 
primary aim of the study. 
Sociodemographic variables.  Items from the from the Behavioral Risk Factor 
Surveillance System questionnaire were used to collect information on age, race/ethnicity 
(CDC, 2010), and items from the Maternal Infant Health Assessment  were used to assess 
education level and household income (Braveman, Cubbin, Marchi, Egerter, & Chavez, 
2001). Responses to the race/ethnicity measure were collapsed into two categories, HL 
vs. non-HL.    
Active transportation.  The four transport-related physical activity questions 
from the International Physical Activity Questionnaire (IPAQ) long form were used to 
measure active transportation.  Two questions were asked for both bicycling and walking, 
including how many days in the past seven did you walk (cycle) to go from place to place 
for at least 10 minutes and how much time in hours and minutes did you usually spend on 
those days walking (cycling) from place to place.  Total minutes per week of active 
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transportation were calculated and used in the analyses as a continuous variable. All 
active transportation users reported walking in the past week, but only six reported 
cycling.  The IPAQ has established reliability (rs = 0.80) but somewhat low criterion 
validity (Craig et al., 2003; Lee et al., 2011; Lee et al., 2011).  The additional measure of 
active transportation used at the time of POCT included six questions from the 2009 
National Household Travel Survey (NHTS) (Federal Highway Administration, 2009).  A 
participant was classified as an active transportation user if she self-reported active 
transportation use on either the IPAQ or the NHTS questionnaire.   
Cardiometabolic syndrome risk factors.  Each CMS risk factor in the study was 
analyzed as both a continuous (i.e., each risk factor in its original physical metric) and 
dichotomous (i.e., absence vs. presence of risk factor) measure.  Variables were 
objectively measured by trained research assistants using a detailed protocol.  Cut points 
to determine the presence or absence of each CMS risk factor were based on ATP III 
criteria (Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol 
in Adults, 2001; Grundy et al., 2005).  Each participant was provided with a copy of her 
results, and anyone with abnormal results was advised to seek medical care and provided 
with a list of local clinics where they could obtain free or reduced-cost health care.   
SBP and DBP were measured twice after participants sat quietly with both feet on 
the floor for 2 minutes using an automatic sphygmomanometer.  Assessments were 
separated by one minute, and if either of the two measurements differed by at least 10 
mmHg, a third was obtained.  The two measurements were averaged and used as the 
continuous variable in the analyses, and if a third measurement was necessary, the two 
closest measurements were used.  Blood pressure was transformed into a dichotomous 
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variable with participants having a SBP ≥ 130 mmHg, a DBP ≥ 85 mmHg, and/or self-
reported medication for or diagnosis of high blood pressure/HTN classified as having 
HTN (Grundy et al., 2005; International Diabetes Federation, 2006).   
WC was measured twice to the nearest 0.1 cm at the level of the umbilicus with a 
tape measure using a modified CDC protocol.  If the measures differed by at ≥ 1 cm, a 
third measurement was obtained.  The two closest measurements were averaged and used 
in the analysis as the continuous variable.  The presence of abdominal obesity was 
determined by a WC ≥ 88 centimeters (Grundy et al., 2005; International Diabetes 
Federation, 2006).   
FG, TG, and HDL values, assessed using the POCT CardioChek Plus (Polymer 
Technology Systems Inc., Indianapolis, Indiana), were collected according to 
manufacturer’s directions (Polymer Technology Systems Inc., 2018), after the participant 
had fasted for at least eight hours. Testing using capillary blood via POCT is less invasive 
than venous blood draws, and meets industry standards for accuracy (Bastianelli, Ledin, 
& Chen, 2016).  Participants were asked to place the hand of their choosing in a 
dependent position while materials were arranged.  The third or fourth finger was 
prepped with an alcohol and allowed to dry before puncturing the skin with a sterile 
lancet.  The blood sample was directly applied to the eGLU strip and then wiped with 
gauze.  The finger was then milked until a large drop was obtained and drawn into a 
collection pipette to the amount indicated.  The sample was then expressed onto the lipid 
panel test strip for analyzing.  The resulting values were used in the analyses as 
continuous variables.  Participants were classified as having elevated FG if their FG value 
was ≥ 100 mg/dL, they had been diagnosed with T2DM, or were taking medication for 
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elevated blood sugar, prediabetes, or T2DM.  Participants with TG values ≥150 mg/dL 
were classified as having high TG, and those with HDL values < 50 mg/dL were 
classified as having low (vs. normal) HDL (Grundy et al., 2005; International Diabetes 
Federation, 2006).   
Cardiometabolic syndrome.  The presence of CMS was operationalized 
according to ATP III criteria.  CMS was defined as having the presence of at least three 
of the five cardiometabolic risk factors described above (Grundy et al., 2005).   
Physical activity.  Participants were instructed to wear Actigraph GT3X+ 
accelerometers, the gold standard to measure physical activity, at the right hip for 7 days, 
except when exposed to water (ActiGraph, 2018; Welk, 2005).  Participants were given 
written instructions for the accelerometer and asked to complete a daily log (provided in 
either English or Spanish) to document wear time.  Accelerometers were preset and data 
were downloaded at 60-second epochs (Layne et al., 2015; Ward, Evenson, Vaughn, 
Rodgers, & Troiano, 2005).  
 Accelerometer data tracings were visually inspected to determine sleep and wake 
times and compared to self-reported wear time that participants documented on their 
daily logs.  Wear time was validated using the Choi 2011 algorithm in the ActiLife 
software (Choi, Liu, Matthews, & Buchowski, 2011) and Freedson 1998 physical activity 
cut points were used (Freedson, Melanson, & Sirard, 1998).  Only participants with ≥ 10 
valid hours of wear time per day for ≥ three days within a seven-day period were 
included in the analysis (Welk, 2005).  Moderate and vigorous minutes per day were 
summed and multiplied by seven to determine moderate to vigorous physical activity 
(MVPA) minutes per week.  MVPA was dichotomized into yes/no for participants based 
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on whether they met national MVPA recommendations of ≥ 150 minutes per week 
(Physical Activity Guidelines Advisory Committee, 2018).  Light, moderate, vigorous, 
and very vigorous minutes per day were summed to determine total daily physical 
activity and used in the analyses.   
Body mass index.  Trained research assistants measured participants’ height to 
the nearest 0.25 inch using a Stadiometer for use in the calculation of body mass index 
(BMI).  The Tanita total body composition analyzer model TBF- 310 (Tanita, Arlington 
Heights, IL) was used to measure BMI.  The average of two BMI values was used as a 
continuous covariate in the analyses.  BMI was transformed into underweight, normal 
weight, overweight and obese according to CDC criteria (CDC, 2017) for descriptive 
analyses. 
Statistical Analyses 
 Univariate analyses, plots, standardized residuals, leverage, and Cook’s Distance 
were used to assess distributions, outliers, and influential data.  Intra-class correlations 
were calculated for each CMS risk factor, total physical activity, and MVPA to determine 
the strength of within-ECEC clustering (non-independence) of outcome scores.  
Descriptive analyses using means, standard deviations, and/or percentages were 
conducted for sociodemographic variables (age, race/ethnicity, education level, 
household income), BMI, minutes of active transportation, continuous outcomes (SBP, 
DBP, WC, FG, TG, HDL, CMS risk factor counts (0-5), weekly MVPA minutes, and 
total physical activity minutes per day), and dichotomous outcomes (HTN, abdominal 
obesity, prediabetes/T2DM, high TG, low HDL, CMS, met MVPA recommendations) for 
the sample, and by active transportation use (any vs. none).  Chi-square and two-sample 
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t-tests were used to examine associations between active transportation versus no active 
transportation groups with covariates (age, HL/non-HL, BMI), CMS outcomes, and 
physical activity variables. Covariates, CMS outcomes, and physical activity variables 
were also compared across race/ethnicity (HL vs. non-HL).  Bivariate correlations for 
sociodemographic variables (age, race/ethnicity, education level, household income), 
minutes of active transportation, active transportation use (any vs. none), CMS outcomes, 
physical activity variables, and BMI were conducted.   
Separate multivariable logistic regression models were used to determine the 
association between the dichotomous measure of active transportation use (any vs. none) 
and each of the dependent variables (presence vs. absence of each CMS risk factor, 
presence vs. absence of CMS, and meeting MVPA recommendations), while adjusting 
for age and HL/non-HL (all outcomes) and BMI (CMS outcomes only).  Multivariable 
linear regression analyses were conducted to examine associations of active 
transportation use (any vs, none) and minutes of active transportation use with each of the 
continuous cardiometabolic outcome and physical activity variables, adjusting for age, 
and race/ethnicity (for all outcomes) and BMI (for CMS outcomes only).  Participants 
were only included in an analysis if they had complete data on all variables used in the 
analysis.  Analyses were conducted using SPSS version 23.0 with a significance level set 
at 0.05.  
Results 
Sample Characteristics and Bivariate Associations 
The total sample consisted of 64 women, 42 (66%) of whom reported using active 
transportation.  Of the 46 women who self-reported that they were not previously 
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diagnosed with or prescribed medication for prediabetes/T2DM, 12 (26%) had elevated 
FG.  Of 48 women who denied a previous diagnosis of or medication for HTN, 3 (6%) 
had HTN by objective measure. 
Table 4.1 presents descriptive characteristics for the entire sample and by active 
transportation use (any/none), including means and standard deviations for age, BMI, 
active transportation minutes per week, walking active transportation, and cycling active 
transportation.  The sample prevalence of dichotomous variable outcomes (CMS risk 
factors, CMS, and met MVPA guidelines) and the means with standard deviations of 
continuous variable outcomes (CMS risk factors, weekly MVPA minutes, and total 
physical activity minutes per day) and by active transportation use are presented in Table 
4.2.   
Preliminary Regression Diagnostics 
 In preliminary linear regression analyses, one participant’s value for minutes of 
active transportation from the IPAQ was found to be highly influential based on high 
standardized residual, leverage, and Cook’s Distance values in models for all outcomes. 
Linear regression models estimated with and without the data point showed no difference 
in patterns of significant associations for any outcome. Accordingly, this participant was 
excluded from all statistical analyses, including descriptive and bivariate analyses, 
involving minutes of active transportation, but classified as an active transportation user 
for and included in logistic regression analyses.  Three participants had a single outlier 
value, one for FG, TG, and HDL.  Linear regression models were conducted with and 
without these data points and there were no changes in patterns of significant associations 
for any of the three outcomes.  Each data point was excluded from the descriptive and 
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bivariate analyses when using continuous values, and respective linear regression models 
due to ±3 standard deviations from the mean.  These participants’ raw values were 
transformed into their corresponding dichotomous outcomes and included in descriptive 
and bivariate analyses, and logistic regression models as dichotomous values.  Intraclass 
correlations were conducted for each continuous outcome (SBP, DBP, WC, FG, TG, 
HDL, MVPA, and total physical activity) with little evidence of clustering (ICC = -0.08 
to 0.18). 
Bivariate Associations 
HL women had lower SBP (M=106.91, SD=11.89) and DBP (M=71.83, 
SD=10.65) than non-HL women (M = 113.73, SD = 7.08; M = 76.15, SD = 5.79), both of 
which approached significance (t(61) = 1.97, p = .053, d = .70; t(35.67) = 1.96, p = .057, 
d = .50), respectively.  There was a significant relationship between race/ethnicity and the 
presence of CMS, χ2 (1, N = 64) = 4.31, p = .038, with HL women being more likely to 
meet criteria for CMS than non-HL women.  There were no other significant associations 
between race/ethnicity and other variables.   
Age was significantly positively correlated with SBP (r = .30, p = .015) and DBP 
(r = .25, p =.044).  Income was positively correlated with education (r = .30, p =.045).  
No other sociodemographic variables were related to any of CMS risk factors and 
physical activity outcomes.  BMI was significantly related to WC (r = .90, p <.001), FG 
(r = .26, p =.044), TG (r = .36, p = .005), and the number of CMS risk factors (r = .49, p 
<.001).  Bivariate correlations between active transportation use, CMS outcomes, and 
physical activity variables are presented in Table 4.3. 
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Attrition Analyses 
A significantly higher proportion of non-HL women (n = 11; 85%) had valid 
accelerometry data than HL women (n = 28; 55%), (χ2 (1, N = 64) = 3.84, p = .050).  Of 
those who did not have valid accelerometry data (n = 25), more were active 
transportation users (n = 20; 80%) than those who did not use active transportation (n = 
5; 20%) (χ2 (1, N = 64) = 3.76, p = .053), and this approached significance.  Women who 
had accelerometry data had significantly lower FG (M = 92.79, SD = 12.49) and number 
of CMS risk factors (M = 1.89, SD = 1.10) than women who did not have accelerometry 
data (M = 102.83, SD = 26.89; M = 2.56, SD = 1.36; t(61) = 2.01, p = .049; t(62) = 2.15, 
p = .036), respectively.  There were no other significant differences in women who had 
valid accelerometry data than those who did not. 
There were significantly more women included in the linear regression analyses 
(i.e., women with data on self-reported active transportation minutes) that had 
accelerometry data (82%) than those who were excluded (i.e., did not have data for self-
reported active transportation minutes) (18%), (χ2 (1, N = 64) = 6.59, p = .010).  There 
was a significantly lower proportion of women excluded from linear regression who had 
normal HDL (5%) compared to those included (95%), (χ2 (1, N = 64) = 8.49, p = .007).  
The women included in the linear regression analyses had higher HDL (M = 44.47, SD = 
11.27) than those excluded (M = 38.94, SD = 4.86; t(60.55) = -2.72, p = .009).  There 
were no other differences in sociodemographic variables or CMS risk factors in women 
with and without valid accelerometry data or those who were excluded from the 
regression analyses.  
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Logistic Regression Models 
 In logistic regression models, adjusting for age, race/ethnicity, and BMI, active 
transportation use (none vs. any) was not related to HTN, abdominal obesity, elevated 
FG/T2DM, elevated TG, low HDL, or CMS (ps > .05).  The odds of engaging in ≥ 150 
minutes of MVPA per week was over seven times higher for women who used active 
transportation (OR = 7.174, 95% CI [1.50, 34.41]) than for those who do not use active 
transportation (p = .014, Q = .66), after adjusting for age and race/ethnicity. 
Linear Regression Models 
 In linear regression models, between active transportation use was not 
significantly related to SBP, WC, FG, TG, HDL, or number of CMS risk factors (ps > 
.05), after adjusting for age, race/ethnicity, and BMI.  There was some evidence that 
women who used active transportation had lower DBP, but this association was not 
significant at p < .05 (B = -4.517, t = -1.735, p = .088, d = .52).  No associations were 
found between active transportation use and weekly MVPA minutes or total physical 
activity minutes per day, after adjusting for age and race/ethnicity (ps > .05). 
Minutes of active transportation use was not significantly related to SBP, DBP, WC, FG, 
TG, HDL, or number of CMS risk factors (ps > .05), when adjusting for age, 
race/ethnicity, and BMI.  Similarly, minutes of active transportation use was not 
associated with weekly MVPA minutes (p > .05), when adjusting for age and 
race/ethnicity.  Minutes of active transportation per week was positively related to total 
physical activity (B = .197, t = 3.226, p = .003), accounting for 29% of the variance in 
this outcome (R2 = .29, F[3, 28] = 3.866, p = .020).  
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Discussion 
 The purpose of this study was to determine the association between active 
transportation and CMS risk factors, CMS, and physical activity levels among primarily 
HL women.  This is the first study investigating the association between active 
transportation and objective measures of CMS risk factors.  The results from this study 
failed to support a relationship between active transportation, CMS risk factors, or CMS 
although we did find limited support that DBP was lower among active transportation 
users than those who did not use active transportation.   
This is contrary to what some previous studies have found.  According to a meta-
analysis by Hamer and Chida (2008), active transportation was significantly associated 
with cardiovascular health, with even larger protective benefits for women.  Active 
transportation users were less likely to have T2DM (Dinu et al., 2019; Furie & Desai, 
2012) and high blood pressure (Furie & Desai, 2012; Saunders et al., 2013) than non-
users.  In other previous research, similar to our findings, no relationships were found 
between active transportation and HDL (Furie & Desai, 2012) and CMS (Churilla & 
Fitzhugh, 2012; Kuwahara et al., 2016).  Furthermore, the significant relationships found 
between active transportation and some CMS risk factors were only significant for high 
levels of active transportation (Furie & Desai, 2012; Saunders et al., 2013).  This could 
suggest that use of active transportation in this sample was insufficient in duration or 
intensity to result in improvements in cardiometabolic health.   
The active transportation users in our sample were more likely to meet the 2018 
weekly aerobic recommendations of at least 150 minutes per week of MVPA than those 
  95 
who did not use active transportation; however, we did not find a dose response 
relationship between minutes of active transportation and MVPA.  We did confirm a dose 
response relationship between minutes of active transportation and total physical activity 
among active transportation users. This provides some evidence that active transportation 
does have a beneficial relationship with total minutes of physical activity among these 
women, similar to the literature (Physical Activity Guidelines Advisory Committee, 
2018; Wanner et al., 2012).   
In a meta-analysis of physical activity interventions, the majority of included 
studies consisted of minority adults, predominantly women, participating in observed 
physical activity interventions lasting almost 40 minutes at moderate intensity, 
approximately three times per week for 11 weeks (Conn, Phillips, Ruppar, & Chase, 
2012).  These physical activity interventions did not significantly improve lipids or 
T2DM risk.  Approximately 86% of the studies included in the meta-analysis had 
samples with more than half being overweight and/or obese (Conn et al., 2012).  More 
than half of the women in our study who wore accelerometers met weekly MVPA 
recommendations; however, approximately 82% of our sample was either overweight or 
obese and had abdominal obesity.  This could indicate that the MVPA recommendations 
to improve cardiometabolic health may be different for overweight or obese minority 
women.  Future research should include experimental studies investigating active 
transportation interventions at different intensities and bout lengths among HL women of 
different BMI classifications. 
Although we did not find statistically significant relationships between active 
transportation and CMS risk factors, our findings are clinically relevant. Approximately 
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6% of the sample met criteria for undiagnosed HTN.  Untreated HTN increases risks for 
heart disease-, cerebrovascular-, and cardiovascular disease-related mortality, as well as 
all-cause mortality (Zhou, Xi, Zhao, Wang, & Veeranki, 2018).  More than 25% of the 
sample met criteria for undiagnosed prediabetes or T2DM.  Over time, uncontrolled 
blood sugar can cause blindness, renal disease, and cardiovascular disease (CDC, 2019b).  
Both of these conditions increase risks for early morbidity and mortality (Pratley, 2013; 
Zhou et al., 2018) demonstrating the need to screen and treat HL women with 
undiagnosed HTN and prediabetes/T2DM to improve health outcomes of this population.  
The cardiometabolic health of active transportation users was better than those 
who did not use active transportation.  The mean values for all CMS risk factors and 
CMS risk factor counts were in the expected direction except for FG, which could be 
explained by those women controlling their FG with medication for prediabetes/T2DM.  
For example, 31% of active transportation users met the criteria for prediabetes/T2DM 
compared to 31.8% on non-users, even though the mean FG was 97.62 for active 
transportation users and 94.62 for those who did not use active transportation.  The mean 
BMI value for the present sample was considered obese; however, active transportation 
users’ BMI was significantly lower than those who did not use active transportation, with 
the non-users approaching class 2 obesity (CDC, 2017).  Thirty-six percent of the women 
who used active transportation had CMS compared to 50%, which places the women who 
do not use active transportation at even higher risks for cardiovascular disease, stroke, 
T2DM, and cancer (National Heart Lung and Blood Institute, n.d.) than active 
transportation users.   
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Strengths and Limitations 
This was the first study investigating active transportation use with objective 
measures of SBP, DBP, WC, FG, TG, and HDL among primarily HL women, who are 
understudied in the active transportation literature (Dinu et al., 2019; Furie & Desai, 
2012; Hamer & Chida, 2008; Saunders et al., 2013; Wanner et al., 2012; Xu et al., 2013) 
and disproportionately affected by CMS (Moore et al., 2017).  Previous diagnosis of and 
medication prescribed for HTN and prediabetes/T2DM was measured and included in the 
assessment of CMS risk factors.  Physical activity was measured objectively using 
Actigraph accelerometers, and the IPAQ has established reliability for HL women (Craig 
et al., 2003).        
This study does include some limitations.  The small sample size limits the power 
to detect statistical significance in associations, and makes the interpretation of results 
somewhat difficult.  Subjective measure for active transportation use and minutes of 
active transportation use may be biased due to overestimation.  The use of accelerometers 
alone does not allow for measurement of active transportation use.  Due to the cross-
sectional design, the ability to draw causal inferences is limited.   
Conclusion 
Active transportation use was not related to CMS risk factors or CMS in this 
group of primarily HL women; however, it was associated with meeting weekly MVPA 
recommendations and total physical activity levels.  The HL women who used active 
transportation had better health outcomes compared to those who did not use active 
transportation, and even though this was not statistically significant, this has significant 
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clinical relevance.  Health practitioners should recommend active transportation use to 
HL women as a way to achieve the recommended MVPA guidelines and increase total 
physical activity when possible, while potentially improving cardiometabolic health.  
Additionally, HL women should be screened for HTN and prediabetes/T2DM when 
possible for early detection and treatment to improve health and prevent long-term 
sequelae.  Policymakers should work with urban planners to improve the built 
environment to promote active transportation.  Future research should investigate the 
relationship between active transportation use and CMS risk factors and CMS with large 
samples of HL women.  This should include various intensities and durations using 
objective measures among HL women of different BMI classifications to determine more 
tailored MVPA recommendations to decrease SBP, DBP, WC, FG, and TG, and increase 
HDL.  The findings of this study indicate there may be unidentified factors that influence 
the relationship of active transportation and physical activity with cardiometabolic health 
among primarily HL women that require further exploration.   
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CHAPTER 5 
DISCUSSION 
The purpose of this body of research was to investigate the existence of 
relationships between active transportation, walking active transportation, physical 
activity and cardiometabolic health among adults, including African American and 
Hispanic/Latina women.  This was guided by the Ecological Model of Physical Activity 
(EMPA) and Ecological Model of Obesity (EMO), which was extended to include active 
transportation as the physical activity exposure and cardiometabolic risk factors and 
syndrome as the health outcomes, and physical activity as an additional outcome (see 
Figure 1.1).  The EMPA and EMO are dynamic frameworks that were used to guide 
variable selection at multiple environmental levels that may directly and/or indirectly 
interact to influence active transportation, physical activity, and cardiometabolic health, 
while accounting for intra-individual factors (Lee et al., 2015; Lee & Cubbin, 2009; 
Spence & Lee, 2003).   
In Chapter 2, a systematic review was conducted to determine the association 
between walking active transportation, the most common form of active transportation, 
and cardiometabolic syndrome and risk factors among adults.  This systematic review 
indicated that adults who used walking active transportation had smaller waist 
circumference, lower presence of abdominal obesity, and lower blood pressure (presence 
of hypertension).  Relationships between walking active transportation and high-density 
lipoproteins/low levels of high-density lipoproteins, triglycerides/hypertriglyceridemia, 
fasting glucose/type 2 diabetes mellitus, and/or cardiometabolic syndrome were found. 
None of the studies included in the systematic review found significant results in 
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opposition to our hypothesis.  The systematic review revealed significant design and 
statistical heterogeneity among active transportation studies, including definitions and 
measures of active transportation, comparators, and criteria to determine 
presence/absence of cardiometabolic risk factors (see Table 2.4).  Studies tended to be of 
low quality, and the overall measurement of active transportation was crude, indicating 
the need for future research with objective measures of active transportation.  The 
number of covariates adjusted for and the domains represented by them  varied across 
studies, with variables drawn from the micro- (e.g., site, location of employment) and 
macro-environmental levels (e.g., socioeconomic status, race/ethnicity, air pollutants) of 
the EMPA/EMO, and intra-individual factors, including biological (e.g., sex, age, body 
mass index, family history) and behavioral (e.g., education diet, nicotine use) factors (see 
Table 2.3). 
The purpose of Chapter 3 was to investigate the relationship between active 
transportation, physical activity, and cardiometabolic risk factors among African 
American and Hispanic/Latina women from two cities in Texas, and examine those 
associations by ethnicity (macro-environment).  This investigation failed to find a 
significant relationship between active transportation use and cardiometabolic health for 
the sample of women or by race/ethnicity; however, systolic blood pressure was slightly 
lower and accelerometry-measured moderate to vigorous physical activity (MVPA) was 
higher for active transportation users, but not significantly so.  MVPA was significantly 
inversely associated with diastolic blood pressure and body fat, but not body mass index, 
systolic blood pressure, or resting heart rate in the entire sample of women.  When 
investigating this relationship within race/ethnicity groups, diastolic blood pressure was 
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no longer significant, but the association with body mass index became significant in the 
expected direction for African American women, and MVPA remained inversely 
associated with body fat for both African American women and Hispanic/Latina women.  
Interestingly, accelerometry-measured mean minutes of MVPA for African American 
women was 177 minutes per week, while Hispanic/Latina women had, on average, only 
66 minutes per week.  Even though the African American women in this sample, on 
average, exceeded the 2018 recommendations for weekly MVPA minutes, higher MVPA 
was not significantly associated with lower systolic or diastolic blood pressure in this 
group.  Furthermore, even though, on average, women in the sample participated in 
approximately 140 minutes of MVPA per week, the mean body mass index met the CDC 
criteria for obesity.  These findings demonstrated the presence of significant differences 
in MVPA participation and cardiometabolic health outcomes by ethnicity, which is 
consistent with the EMPA/EMO (Lee et al., 2015; Lee & Cubbin, 2009; Spence & Lee, 
2003). 
Chapter 4 explored the relationship between active transportation and 
cardiometabolic risk factors, cardiometabolic syndrome, and physical activity levels 
among primarily Hispanic/Latina (macro-environment) women (biological factor) living 
in an urban city in Arizona.  Active transportation use was not found to be significantly 
related to the presence of cardiometabolic syndrome or risk factors among the women in 
the sample.  Minutes of active transportation was also not significantly related to lower 
systolic or diastolic blood pressure, waist circumference, fasting glucoses, triglycerides, 
number of cardiometabolic syndrome risk factors, or higher levels of high density 
lipoproteins; however, there was some evidence that women who used active 
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transportation had lower diastolic blood pressure.  Furthermore, active transportation 
users had less prevalence of cardiometabolic risk factors than non-users, even though 
these differences were not significant.  A significant dose-response was found between 
minutes of active transportation use and minutes of total physical activity, and women 
who used active transportation were seven times more likely to meet the 2018 national 
aerobic recommendations of 150 minutes of MVPA per week than those who did not use 
active transportation.  Although the mean minutes of accelerometry-measured MVPA 
was greater than the 2018 national weekly MVPA recommendations, this group of 
women met criteria for multiple cardiometabolic risk factors and most were obese based 
on CDC criteria.  Furthermore, 6% of the women had undiagnosed hypertension and 25% 
had undiagnosed type two diabetes mellitus.   
Integration of Studies 
This dissertation provides some evidence that adults and ethnic minority women 
who used active transportation have lower blood pressure than those who did not, 
although this difference was not significant. Active transportation users had more minutes 
of physical activity using objective and subjective measures.  Both of these findings have 
clinical significance for public health, especially because blood pressure contributes to 
early mortality and cardiovascular diseases (Bundy et al., 2017), which is the leading 
cause of death worldwide (World Health Organization, 2017).  Replacing sedentary 
behavior with any amount of physical activity can improve cardiometabolic health 
(Physical Activity Guidelines Advisory Committee, 2018); therefore, active 
transportation should be encouraged to increase physical activity.  
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When looking at the findings through the lens of the EMPA/EMO, some themes 
become apparent.  It emerged that biological difference based on sex may exist that 
moderate the relationship between walking for active transportation and cardiometabolic 
syndrome (Boone-Heinonen et al., 2009; García-Hermoso et al., 2018; Xiao et al., 2016).  
This has also been found in physical activity research (Zhang et al., 2017), but a large 
body of conclusive evidence to make active transportation or MVPA recommendations 
based on sex is lacking (Physical Activity Guidelines Advisory Committee, 2018).  It is 
vital that future research investigating active transportation, physical activity, and 
cardiometabolic syndrome explore relationships based on sex.  This should also include 
an exploration into how active transportation use may be influenced by neighborhood 
safety for women compared to men. 
Interestingly, both samples of minority women had MVPA levels that are related 
to benefits to cardiometabolic health among adults (Physical Activity Guidelines 
Advisory Committee, 2018); however, the women in these studies were mostly obese 
with a number of cardiometabolic risk factors present.  This may suggest that the amount 
of MVPA needed to translate to improved cardiometabolic health may be different for 
obese minority women, and may be explained by biological and cultural differences 
(macro-level), consistent with the EMPA/EMO (Lee et al., 2015; Lee & Cubbin, 2009; 
Spence & Lee, 2003).   
The methods used to measure active transportation throughout the studies, both 
walking and cycling, are of low quality and fail to consistently demonstrate adequate 
validity and reliability.  Without objective measures of active transportation that are able 
to adequately operationalize the concept of active transportation, it will be difficult, if not 
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impossible, to determine the presence or absence of any relationships between active 
transportation and cardiometabolic syndrome.  Criteria to define active transportation 
based on specific interval amounts (e.g., none, less than 30 minutes per day, greater than 
30 minutes per day) should be established as an industry standard to allow for 
comparisons across studies.  Collecting active transportation data with accelerometry, 
geographical positioning systems, and geographic information systems would allow for 
objective measure of active transportation, along with data collection from various levels 
of the EMPA/EMO.  This would enable simultaneous investigation into the linkage 
between intra-individual factors and extra-individual environmental variables that 
influence active transportation use and cardiometabolic syndrome (Spence & Lee, 2003) 
The EMPA and EMO hypothesize that there are numerous factors that directly 
and indirectly influence active transportation and cardiometabolic syndrome.  The lack of 
significant associations could be attributed to the absence of critical contextual variables 
related to active transportation and cardiometabolic syndrome that were not included in 
this dissertation.  For example, the relationship of dietary behavior (intra-individual 
factor) and cardiometabolic syndrome was not investigated or controlled for; however, 
diet and physical inactivity are the two largest lifestyle contributors to cardiometabolic 
syndrome (Saklayen, 2018) demonstrating the need to address this with future studies.  
The neighborhood (micro-level environment) and walkability indices (macro-level 
environment) of an individual’s home, work, and/or school may interact with active 
transportation use and/or diet, which could influence cardiometabolic syndrome (Lee et 
al., 2015; Lee & Cubbin, 2009; Spence & Lee, 2003). 
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Strengths and Limitations 
 This body of research was the first to investigate walking active transportation 
and cardiometabolic risk factors and syndrome among adults and linkages between active 
transportation, cardiometabolic risk factors and syndrome, MVPA, and race/ethnicity 
among primarily Hispanic/Latina and/or African American women.  The cardiometabolic 
outcome measures throughout the chapters were objectively measured, except for one 
study included in Chapter 2 (Tajalli & Hajbabaie, 2017).  Furthermore, the sample sizes 
in Chapter 2 and 3 were quite large, and MVPA was objectively measured using 
accelerometers, which is the gold standard.  Overall, this dissertation adds important 
findings to the literature that provide evidence-based recommendations to advance active 
transportation research.  
There were also some limitations present in this dissertation, including the 
subjective methods used to measure active transportation throughout the studies.  
Limitations also exist with accelerometry-measured physical activity, including the 
inability to measure upper body, bicycling, and swimming activity (Al-Eisa, Alghadir, & 
Iqbal, 2016) and the physical activity domain (transport, occupational, household, leisure-
time) one is engaged in.  The placement of accelerometers at the hip should be secure and 
consistent to minimize measurement error, which can be difficult with obese research 
participants (Beechy, Galpern, Petrone, & Das, 2012).  The mean body mass index for 
the samples from both Chapters 3 and 4 met the CDC criteria for obesity, potentially 
making it difficult to determine associations and differences in outcomes that are related 
to obesity.  Chapter 4 had a small sample size limiting the potential to detect significant 
associations and ability to control for important contextual variables aligned with the 
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EMPA, such as income, education, number of children, and food insecurity that could 
influence cardiometabolic syndrome.     
Implications 
Research Implications 
 Future research should focus on developing and/or incorporating a combination of 
objective measures of walking for active transportation to allow for differentiation 
between domains of physical activity.  This should include studies with consistent 
definitions and cut-off criteria for active transportation use with similar comparators to 
allow for findings to be quantitatively synthesized in meta-analysis.  Published criteria to 
determine the presence/absence of cardiometabolic syndrome risk factors that was 
established through consensus within the international community should be used to 
allow for consistency across studies and to maximize external validity (Alberti et al., 
2009).    
This research has generated additional research questions to be explored through 
qualitative research methods.  Guided by the EMPA, research should be conducted to 
investigate which contextual and/or psychological variables may be mediating and/or 
moderating the relationships between active transportation, physical activity, and 
cardiometabolic syndrome.  This should include interviews with the Hispanic/Latina 
women that participated in the study from Chapter 4 that explore the context surrounding 
active transportation use and physical activity in hopes of developing multi-level 
interventions to target mediators and/or overcome moderators to improve 
cardiometabolic health.  Additional qualitative research should include exploring the 
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barriers these women experience that may prevent them from being screened, diagnosed, 
and/or treated for undiagnosed hypertension and type 2 diabetes mellitus.     
Future research should investigate culturally specific mediators that influence 
walking for active transportation, physical activity, and cardiometabolic health among 
African American and Hispanic/Latina women.  This could potentially provide an 
opportunity to develop multi-level interventions specific to race/ethnicity.  Interventions 
that include macro-level environmental variables have the potential to affect larger 
numbers of individuals that could improve public health (Lee et al., 2015; Lee & Cubbin, 
2009; Spence & Lee, 2003).   
Large randomized controlled trials should be conducted to investigate the causal 
effects of walking for active transportation on cardiometabolic syndrome and 
accelerometry-measured physical activity among ethnic minority women.  This should 
include objective measures of walking for active transportation at different frequencies, 
durations, and intensity levels among women of all body mass index classifications.  This 
is necessary to determine prescriptive walking for active transportation recommendations 
to improve cardiometabolic syndrome risk factors based on race/ethnicity, sex, and body 
mass index classification.  Biological factors, such as sex and body mass index, must be 
considered when making active transportation recommendations to maximize 
intervention effectiveness on cardiometabolic health.   
Practice Implications 
 Healthcare providers should recommend walking active transportation to their 
patients, when appropriate, to increase MVPA and total physical activity, especially 
among African American and Hispanic/Latina women.  Even though active 
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transportation was only found to be related to lower risks for hypertension in one study in 
this dissertation, many cardiometabolic health outcomes were more normal for ethnic 
minority active transportation users compared to non-users, especially systolic blood 
pressure.  This is relevant and important because high systolic blood pressure increases 
cardiovascular and all-cause mortality, and is a significant predictor for cardiovascular 
disease (Bundy et al., 2017), which is the leading cause of death in the world (World 
Health Organization, 2017).   
 It is important for health care providers to consider the context surrounding active 
transportation when recommending use, especially for ethnic minority women.  One 
barrier to active transportation is the long commuting distances to work or school (Lee, 
Adamus-Leach, Cheung, et al., 2012).  This could be ameliorated by health care 
providers recommending that any passive travel within walkable distances be replaced 
with active transportation.   Unsafe neighborhoods have been identified as a barrier to 
physical activity among ethnic minority women (Joseph et al., 2015; Mama et al., 2015); 
however, poor, ethnic minority women have been found to be undeterred by unsafe 
neighborhoods when using active transportation (Lee, Kim, & Cubbin, 2018).  Even so, 
to maximize safety, health care providers should encourage the inclusion of family and/or 
friends when using active transportation, which also would provide social support.   
Healthcare providers should screen African American and Hispanic/Latina 
women for undiagnosed hypertension and type 2 diabetes mellitus based on incidental 
findings.  This could allow for early diagnosis and treatment of these diseases among 
ethnic minority women.   Undiagnosed hypertension and type 2 diabetes mellitus 
increases risks for cardiovascular disease and events, and contributes to early morbidity 
  112 
and mortality (Pratley, 2013; Zhou et al., 2018), which demonstrates the significance for 
early treatment. 
Policy Implications 
 Policymakers should legislate for changes to existing and proposed built 
environment infrastructure and work with city planners to increase walkability for 
pedestrians to encourage participation in active transportation and physical activity.  It is 
vital for policymakers to ensure women have access to affordable healthcare to screen, 
diagnosed, and treat cardiometabolic risk factors.  This could include lobbying for 
healthcare for all, free health screenings, and/or affordable medications to treat 
cardiometabolic risk factors.      
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